Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3028026	p-igm	g/l (g/l)	16994	30894	0.02%
3028026	s-igm	g/l (g/l)	6499	9592	0.04%
3028026	p-igm	— (—)	2356	3287	100.00%	Distribution not available
3028026	s-igm	— (—)	943	1407	100.00%	Distribution not available
3028026	igm	g/l (g/l)	7	7	0.00%	Distribution not available
3028026	s-immunoglobuliinim	g/l (g/l)	6	6	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Methotrexate

910

2330

4.36

322.40

1.9

1.8

1.19

1.36

g/l

2.23

830

2089

ILD, hospital admissions 1, main diag only

896

2304

4.51

319.98

2.1

1.9

1.12

1.41

g/l

3.96

834

2062

Chronic lower respiratory diseases

5766

17836

1.81

319.38

1.8

1.9

1.27

1.31

g/l

0.91

5317

16263

Cardiovascular diseases

3202

8142

2.23

318.35

1.8

1.26

1.32

g/l

0.96

2990

7546

Headache

2967

11693

2.21

318.13

1.9

1.7

1.27

1.34

g/l

1.37

2744

10649

Medical observation and evaluation for suspected diseases and conditions

3317

7990

2.21

317.23

1.9

1.32

1.30

g/l

0.12

2997

7308

Nutritional anaemias

2349

9967

2.43

317.14

2.0

1.9

1.35

1.37

g/l

0.17

2132

9008

MS-disease / Multiple Sclerosis

678

1427

5.81

316.28

3.6

1.7

1.01

1.41

g/l

7.67

666

1323

Acute upper respiratory infections of multiple and unspecified sites

3629

13809

2.05

312.92

2.2

1.8

1.22

1.33

g/l

3.08

3332

12629

Dialysis, with operation codes

889

2313

4.44

312.19

2.4

1.8

1.14

1.31

g/l

1.45

828

2102

Hypertensive diseases (excluding secondary)

2718

7005

2.37

311.67

1.8

1.9

1.19

1.37

g/l

4.65

2507

6459

Iron deficiency anaemia

2060

8504

2.56

309.93

2.0

1.9

1.31

1.37

g/l

0.71

1878

7694

Acute upper respiratory infections

4901

17061

1.86

309.05

2.1

1.8

1.24

1.34

g/l

2.59

4488

15542

Lymphoid leukaemia

543

965

7.30

308.60

2.3

1.8

1.10

1.50

g/l

1.72

485

881

Viral Sepsis

1139

3343

3.78

307.65

2.4

1.8

1.23

1.40

g/l

1.62

1052

3018

Demyelinating diseases of the central nervous system

766

1711

5.40

307.65

3.5

1.7

1.07

1.39

g/l

4.11

751

1587

Diseases of oesophagus, stomach and duodenum

5545

16407

2.15

307.65

1.9

1.33

1.30

g/l

0.41

5042

15010

Explicit Sepsis

2570

8031

3.35

307.65

2.2

1.8

1.22

1.38

g/l

2.79

2349

7258

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

402

361

20.11

307.65

4.9

1.8

0.54

1.67

g/l

4.64

319

328

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

1237

2120

7.27

307.65

3.3

1.4

1.74

1.15

g/l

5.46

1168

1912

Other anaemias

2676

7417

3.87

307.65

2.3

1.8

1.40

1.37

g/l

0.16

2414

6678

Autoimmune diseases related-to ILD

6088

16808

3.49

307.65

2.0

1.8

1.23

1.35

g/l

4.04

5693

15209

Abnormal findings on diagnostic imaging of lung

2426

9322

2.72

307.65

2.0

1.9

1.30

1.36

g/l

0.46

2212

8397

ILD differential diagnosis

3943

8786

2.34

307.65

1.9

1.8

1.27

1.39

g/l

2.09

3645

8020

Cirrhosis of liver, NAS

815

811

17.94

307.65

1.5

1.9

1.53

1.43

g/l

0.37

749

739

Any gastric operation

5060

7375

3.66

307.65

1.9

1.6

1.29

1.31

g/l

0.26

4659

6789

Codeine

4557

12979

2.00

307.65

1.8

1.25

1.35

g/l

2.43

4172

11905

Other interstitial pulmonary diseases

1014

2579

4.54

307.65

2.2

1.9

1.15

1.42

g/l

3.38

941

2292

Implicit bacterial Sepsis

2247

6529

3.45

307.65

2.0

1.9

1.26

1.41

g/l

1.82

2033

5855

Sicca syndrome [Sjögren]

721

1544

5.66

307.65

2.0

1.8

1.34

1.41

g/l

0.36

668

1398

Systemic connective tissue disorders

2685

7072

4.34

307.65

1.9

1.28

1.37

g/l

1.26

2486

6387

Certain disorders involving the immune mechanism

1543

4047

4.45

307.65

3.0

1.8

1.12

1.34

g/l

3.57

1420

3708

GASTRO-related operations

5060

7375

3.66

307.65

1.9

1.6

1.29

1.31

g/l

0.26

4659

6789

Non-follicular lymphoma

868

1662

6.56

307.65

3.2

1.8

1.61

1.33

g/l

1.23

816

1498

Other respiratory diseases principally affecting the interstitium

1123

3054

4.17

307.65

2.1

1.8

1.13

1.40

g/l

4.11

1045

2718

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3597

12865

2.79

307.65

2.0

1.9

1.27

1.35

g/l

0.99

3287

11640

Condition for Implicit Sepsis (Organ dysfunction codes)

4122

14459

2.17

307.65

2.0

1.8

1.25

1.34

g/l

1.88

3740

13190

Purpura and other haemorrhagic conditions

1071

2602

4.86

307.65

2.2

1.9

1.19

1.36

g/l

1.95

990

2373

Other and unspecified anaemias

2662

7344

3.90

307.65

2.3

1.8

1.40

1.37

g/l

0.16

2400

6611

Alcoholic liver disease

948

1553

7.77

307.65

1.4

2.0

1.67

1.33

g/l

3.02

846

1412

Asthma

4272

8701

2.78

307.65

1.8

1.24

1.39

g/l

4.12

3952

7945

Rheumatoid arthritis, including avohilmo

2210

8256

2.91

307.65

1.8

1.9

1.21

1.39

g/l

4.47

2040

7466

Chronic kidney disease

1696

4975

3.75

307.65

2.2

1.9

1.21

1.41

g/l

2.25

1545

4439

Implicit Sepsis

3769

12604

2.46

307.65

2.0

1.9

1.27

1.36

g/l

1.27

3424

11456

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

820

642

23.91

307.65

4.9

1.3

3.44

1.14

g/l

18.05

728

581

Oesophageal varices

525

709

11.02

307.65

1.6

1.9

1.58

1.40

g/l

0.80

483

646

Autoimmune diseases

6834

12794

2.90

307.65

1.9

1.8

1.25

1.32

g/l

1.43

6327

11598

COPD/asthma related infections

5523

12691

2.28

307.65

2.0

1.7

1.25

1.34

g/l

2.26

5034

11602

Aplastic and other anaemias

2892

7999

3.80

307.65

2.3

1.8

1.38

1.37

g/l

0.06

2606

7220

5-aminosalicylic acid

1416

3729

4.23

307.65

2.0

1.8

1.25

1.33

g/l

0.98

1332

3396

Transplanted organ and tissue status

1005

1829

7.07

307.65

2.9

1.8

1.14

1.32

g/l

1.51

942

1689

Immunodeficiencies

749

890

13.58

307.65

4.2

1.7

1.10

1.37

g/l

1.55

679

824

Other bacterial diseases

5728

15130

2.80

307.65

2.1

1.8

1.25

1.33

g/l

1.46

5237

13784

Autoimmune diseases excluding thyroid diseases, strict definition

7270

12384

3.54

307.65

2.0

1.8

1.29

1.32

g/l

0.40

6777

11220

General symptoms and signs

6344

13070

2.56

307.65

1.9

1.7

1.25

1.33

g/l

1.69

5851

11907

Multiple myeloma, excluding all cancers (controls excluding all cancers)

773

636

21.86

307.65

6.1

1.4

0.84

1.16

g/l

1.52

654

572

Asthma, unspecified (mode), excluding more controls

2634

7351

2.98

307.65

1.8

1.29

1.42

g/l

1.61

2421

6679

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1413

1134

22.35

307.65

5.3

1.4

2.36

1.13

g/l

12.37

1227

1021

Asthma, unspecified (mode)

2666

7805

2.87

307.65

1.8

1.29

1.41

g/l

1.59

2447

7105

Non-follicular lymphoma, hilmo, excluding all cancers

868

1429

7.68

307.65

3.2

1.4

1.61

1.15

g/l

2.93

816

1286

Immunodeficiency with predominantly antibody defects

562

482

26.75

307.65

4.5

1.7

0.99

1.34

g/l

2.40

509

449

Oral corticosteroids

8032

13420

3.98

307.65

2.0

1.8

1.24

1.36

g/l

3.93

7431

12144

Other/unspecified seropositive rheumatoid arthritis

1590

5467

3.20

307.65

1.9

1.8

1.22

1.36

g/l

2.42

1476

4935

Reimbursement for rheumatic diseases

4401

12764

3.85

307.65

1.9

1.31

g/l

0.06

4109

11572

Sulfasalazine

1576

5052

3.37

307.65

1.8

1.7

1.23

1.35

g/l

1.92

1467

4553

2520

10051

2.67

307.65

2.0

1.8

1.22

1.32

g/l

1.53

2328

9195

Autoimmune diseases excluding thyroid diseases

7469

12705

3.54

307.65

2.0

1.8

1.29

1.33

g/l

0.56

6960

11518

Azathioprine

1425

2536

6.80

307.65

2.1

1.8

1.21

1.30

g/l

0.84

1334

2311

Rheumatoid arthritis

2044

5937

3.43

307.65

1.8

1.9

1.20

1.39

g/l

4.37

1890

5356

Anaemias

2016

2294

6.63

307.65

2.2

1.7

1.30

1.25

g/l

0.57

1870

2148

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1580

5378

3.24

307.65

1.9

1.8

1.22

1.36

g/l

2.35

1466

4858

L04AA Selective immunosuppressants

2061

4621

5.41

307.65

2.4

1.8

1.15

1.32

g/l

3.73

1951

4235

Nonalcoholic fatty liver disease

1400

1805

11.96

307.65

1.5

1.8

1.20

1.34

g/l

1.57

1260

1664

Asthma (only as main-diagnosis), excluding more controls

3762

8178

2.90

307.65

1.8

1.26

1.40

g/l

2.57

3479

7456

L04AX Other immunosuppressants

4616

12243

4.31

307.65

2.4

1.7

1.12

1.34

g/l

14.12

4262

11183

Budesonide

952

2134

5.10

307.65

2.0

1.8

1.40

1.34

g/l

0.28

876

1935

Other arthritis (FG)

1665

6036

2.97

307.65

1.8

1.9

1.26

1.38

g/l

1.60

1550

5468

Bronchitis

5264

18173

1.98

307.65

2.1

1.8

1.28

1.32

g/l

0.70

4808

16590

Biological medication for rheuma

1189

3430

3.97

307.65

1.6

1.9

1.25

1.26

g/l

0.10

1123

3172

Symptoms and signs involving the circulatory and respiratory systems

5025

13310

1.96

307.65

1.8

1.28

1.33

g/l

0.66

4628

12179

Other diseases of intestines

5151

16493

1.88

307.65

1.9

1.8

1.26

1.31

g/l

0.91

4706

15126

5331

12678

2.81

307.65

2.2

1.7

1.24

1.34

g/l

2.48

4856

11590

Other and unspecified immunodeficiencies with predominantly antibody defects

303

246

37.17

307.65

5.0

1.7

0.83

1.48

g/l

3.31

282

230

COPD differential diagnosis

3943

8789

2.34

307.65

1.9

1.8

1.27

1.39

g/l

2.10

3645

8023

Cardiovascular diseases (excluding rheumatic etc)

3371

9193

2.21

307.65

1.8

1.25

1.34

g/l

1.72

3134

8505

Other pulmonary diagnosis

3965

8786

2.35

307.65

1.9

1.7

1.25

1.39

g/l

2.67

3660

8023

Noninfective enteritis and colitis

2841

10867

2.82

307.65

1.9

1.8

1.25

1.31

g/l

0.84

2655

9922

Symptoms and signs involving the digestive system and abdomen

4920

13148

1.94

307.65

1.8

1.27

1.30

g/l

0.41

4526

11994

Other diseases of liver

2302

3109

10.22

307.65

1.7

1.9

1.29

1.28

g/l

0.04

2069

2863

Coagulation defects, purpura and other haemorrhagic conditions

1345

3909

3.91

307.65

2.2

1.9

1.21

1.34

g/l

1.46

1246

3569

Pain in joint

2915

8660

2.33

307.65

1.7

1.8

1.25

1.35

g/l

2.00

2654

7927

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1861

2966

3.29

307.65

1.8

1.7

1.28

1.27

g/l

0.04

1743

2701

All pneumoniae

5700

17247

2.41

307.65

2.2

1.8

1.24

1.32

g/l

1.66

5196

15783

Abnormal serum enzyme levels

1773

5735

3.38

307.65

1.8

1.9

1.31

g/l

0.03

1659

5170

Chronic hepatitis, not elsewhere classified

534

536

16.59

307.65

2.0

1.8

1.48

1.49

g/l

0.04

494

492

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

7204

15374

3.69

307.65

2.2

1.7

1.30

1.32

g/l

0.28

6583

14032

Cholangitis (primary sclerosing, PSC), with reimbursement 202

413

324

31.92

307.65

3.3

1.6

1.35

1.27

g/l

0.24

400

298

Fever of other and unknown origin

4075

10040

4.18

307.65

2.3

1.8

1.29

1.35

g/l

0.70

3756

9114

Abnormalities of breathing

4756

13226

2.23

307.65

1.8

1.23

1.33

g/l

2.20

4350

12102

Seropositive rheumatoid arthritis, wide

1611

5533

3.20

307.65

1.9

1.8

1.21

1.36

g/l

2.63

1496

4995

Dyspnoea

4354

16711

2.09

307.65

2.0

1.9

1.28

1.33

g/l

0.71

3995

15205

Influenza and pneumonia

6005

17273

2.42

307.65

2.2

1.7

1.24

1.32

g/l

1.88

5479

15822

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

752

1255

7.59

307.65

3.3

1.8

2.47

1.46

g/l

4.94

688

1125

Polyarthropathies

4398

10558

2.99

307.65

1.9

1.25

1.34

g/l

1.63

4050

9641

Multiple myeloma

402

361

20.11

307.65

4.9

1.8

0.54

1.67

g/l

4.64

319

328

ILD medications: immunosuppressive drugs

5996

10768

6.24

307.65

2.4

1.6

1.13

1.38

g/l

14.87

5572

9780

Second line medication for Crohn's disease

4795

12506

4.39

307.65

2.4

1.7

1.12

1.35

g/l

14.08

4429

11420

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5331

12678

2.81

307.65

2.2

1.7

1.24

1.34

g/l

2.48

4856

11590

Metabolic disorders

4578

14772

2.01

307.65

1.9

1.18

1.36

g/l

6.34

4156

13531

Pneumonias (Asthma/COPD co-morbidities)

5688

17115

2.44

307.65

2.2

1.8

1.25

1.32

g/l

1.38

5185

15669

Other systemic involvement of connective tissue

1927

5396

4.03

307.65

1.9

1.36

1.38

g/l

0.16

1781

4877

Heart failure, not strict

3961

11405

2.55

307.65

2.0

1.9

1.20

1.36

g/l

4.49

3631

10329

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5498

17107

2.39

307.65

2.1

1.8

1.24

1.32

g/l

1.41

5005

15660

Asthma-related pneumonia

1948

7268

2.89

307.65

2.1

1.9

1.25

1.35

g/l

0.94

1790

6546

Asthma, excluding more controls

4179

8178

2.88

307.65

1.8

1.23

1.40

g/l

5.29

3866

7456

Bacterial Sepsis

2640

7546

3.40

307.65

2.1

1.9

1.27

1.40

g/l

1.42

2388

6802

Primary biliary cholangitis (PBC)

409

256

32.01

307.65

2.5

1.5

2.70

1.34

g/l

10.86

374

226

5651

15334

2.02

307.65

2.1

1.7

1.29

1.33

g/l

0.55

5161

13981

IBD patients in KELA-register

1602

5094

3.50

307.65

1.9

1.8

1.23

1.31

g/l

1.14

1509

4693

Cholangitis (primary sclerosing, PSC)

696

1006

9.36

307.65

2.8

1.8

1.27

1.45

g/l

0.97

663

914

Asthma (diagnoses ohter than nonallergic)

4247

18929

2.00

307.65

1.8

1.9

1.26

1.33

g/l

1.22

3912

17247

Interstitial lung disease endpoints

1014

2588

4.52

307.65

2.2

1.9

1.15

1.41

g/l

3.31

941

2301

Other systemic involvement of connective tissue (FG)

1870

4531

4.65

307.65

1.9

1.37

1.41

g/l

0.24

1732

4072

First line medication for Crohn's disease

8309

12394

3.99

307.65

2.1

1.6

1.22

1.38

g/l

6.40

7670

11247

Finngen Rheumatological endpoints

5166

13644

2.26

307.65

1.8

1.9

1.28

1.33

g/l

0.87

4755

12450

Inflammatory bowel disease treatment related agents

8716

13974

3.88

307.65

2.0

1.8

1.24

1.35

g/l

3.36

8069

12657

ILD medications: prednisolone, methylprednisolone, prednisone

8269

12300

4.16

307.65

2.0

1.6

1.25

1.39

g/l

4.53

7632

11151

ILD medications

8918

12575

4.28

307.65

2.1

1.6

1.22

1.38

g/l

6.19

8244

11407

ILD medications: azathioprine

1425

2319

7.46

307.65

2.1

1.6

1.21

1.33

g/l

1.34

1334

2123

Enlarged lymph nodes

1227

2744

5.15

307.65

2.4

1.8

1.24

1.37

g/l

0.68

1143

2483

Diseases of liver

4592

6282

9.93

307.65

1.7

2.0

1.46

1.29

g/l

4.37

4155

5735

Ulcerative colitis

1581

5369

3.24

307.65

2.0

1.8

1.25

1.31

g/l

0.81

1487

4924

Infections, IBD-co-morbidities

1155

1537

6.12

307.65

2.1

1.9

1.22

1.42

g/l

1.54

1050

1394

Septicaemia

2477

7216

3.62

307.65

2.2

1.8

1.22

1.40

g/l

3.03

2262

6511

Dental caries

1666

5254

3.46

307.65

2.4

1.8

1.24

1.34

g/l

0.95

1531

4794

ILD, hospital admissions

1009

2565

4.55

307.65

2.2

1.9

1.14

1.41

g/l

3.48

936

2283

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

980

941

9.12

307.65

2.2

2.1

1.16

1.48

g/l

1.98

914

838

Implicit viral Sepsis

1136

3331

3.78

307.65

2.4

1.8

1.23

1.40

g/l

1.61

1050

3008

Seropositive rheumatoid arthritis

1612

4612

3.86

307.65

1.9

1.22

1.41

g/l

3.43

1497

4124

Multiple myeloma and malignant plasma cell neoplasms

762

630

21.66

307.65

6.1

1.4

0.84

1.16

g/l

1.47

645

565

Gastrointestinal diseases

3293

5705

3.04

307.65

1.9

1.8

1.30

1.31

g/l

0.15

3037

5258

Lymphoid leukaemia

543

826

8.59

307.65

2.3

1.4

1.10

1.14

g/l

0.10

485

753

Asthma, hospital admission 2, infections

3240

13330

2.55

307.65

2.0

1.9

1.26

1.32

g/l

0.67

2986

12117

Inflammatory bowel disease, strict (require KELA)

1602

5277

3.37

307.65

1.9

1.8

1.23

1.30

g/l

0.96

1509

4855

Fibrosis and cirrhosis of liver

1270

1126

20.18

307.65

1.8

1.9

1.88

1.41

g/l

4.87

1167

1026

Primary_lymphoid and hematopoietic malignant neoplasms

2892

4198

9.18

307.65

4.0

1.5

1.96

1.20

g/l

11.29

2639

3766

Ascites

629

1121

6.96

307.65

1.6

2.0

1.47

1.51

g/l

0.15

583

1015

Renal tubulo-interstitial diseases

4415

15985

2.23

307.65

2.0

1.8

1.26

1.34

g/l

1.50

4035

14547

Inflammatory bowel disease

2081

7198

3.18

307.65

1.9

1.8

1.26

1.31

g/l

0.72

1958

6602

Colitis, primary sclerosing

325

258

33.42

307.65

3.4

1.5

1.28

1.31

g/l

0.06

317

242

Abnormal findings on examination of blood, without diagnosis

3264

9058

3.78

307.65

2.2

1.8

1.57

1.29

g/l

4.79

3029

8198

Excluding asthma or asthma-COPD overlap

3980

8786

2.36

307.65

1.9

1.7

1.27

1.39

g/l

1.88

3677

8023

Asthma, hospital admissions 3, pneumonia

1956

7293

2.89

307.65

2.1

1.9

1.25

1.35

g/l

0.91

1797

6571

Asthma (mode)

4119

8786

2.71

307.65

1.8

1.25

1.39

g/l

3.37

3812

8020

Other inflammatory liver diseases

683

1038

8.62

307.65

2.0

1.9

1.37

1.34

g/l

0.10

636

950

Other septicaemia

2186

6380

3.69

307.65

2.2

1.9

1.23

1.42

g/l

2.96

2005

5740

Opioids

4888

13247

2.01

307.65

1.9

1.8

1.27

1.35

g/l

1.54

4498

12153

Used for control exclusion in common control thyroid runs

6288

11992

2.81

307.65

1.9

1.8

1.25

1.33

g/l

1.57

5830

10862

COPD/asthma/ILD related infections

5523

12691

2.28

307.65

2.0

1.7

1.25

1.34

g/l

2.26

5034

11602

Any reimbursement code in KELA

3345

5197

3.41

307.65

2.0

1.4

1.25

1.36

g/l

2.08

3125

4752

Bacterial infection, other or unspecified

3366

9124

3.67

307.65

2.2

1.8

1.21

1.37

g/l

2.88

3081

8248

Asthma-related pneumonia or sepsis

1956

7293

2.89

307.65

2.1

1.9

1.25

1.35

g/l

0.91

1797

6571

Tramadol

4030

11724

2.32

307.65

1.9

1.8

1.28

1.36

g/l

1.09

3663

10746

Renal failure

2532

7480

3.39

307.65

2.2

1.9

1.21

1.39

g/l

2.71

2311

6698

Acute renal failure

1240

3477

4.00

307.65

2.1

1.8

1.25

1.41

g/l

1.29

1138

3102

L04AD Calcineurin inhibitors

1037

2230

5.83

307.65

2.6

1.9

1.25

1.26

g/l

0.09

981

2062

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1711

2543

9.19

307.65

1.5

1.9

1.56

1.36

g/l

2.02

1559

2309

Primary_lymphoid and hematopoietic malignant neoplasms

2892

4099

9.40

307.65

4.0

1.5

1.96

1.20

g/l

11.37

2639

3696

Thrombocytopenia, unspecified

664

1249

6.75

307.65

2.2

1.8

1.19

1.43

g/l

1.68

625

1135

Disorders of gallbladder, biliary tract and pancreas

4911

15801

2.09

307.65

2.0

1.9

1.31

1.33

g/l

0.21

4503

14391

Asthma (only as main-diagnosis)

3800

8701

2.78

307.65

1.8

1.27

1.39

g/l

1.95

3514

7945

Pneumonia, organism unspecified

5159

15649

2.53

307.65

2.1

1.7

1.24

1.32

g/l

1.63

4695

14302

Asthma-related infections

3240

13330

2.55

307.65

2.0

1.9

1.26

1.32

g/l

0.67

2986

12117

Malaise and fatigue

2344

7764

2.66

307.65

1.8

1.29

1.38

g/l

0.94

2120

6995

ILD, hospital admission 2, with pulmonary infections

722

1281

6.74

307.65

2.3

1.7

1.08

1.49

g/l

4.37

671

1141

Examination and observation for other reasons

3167

7929

2.55

307.65

1.9

1.29

1.30

g/l

0.06

2930

7254

Interstitial lung disease

1014

2588

4.52

307.65

2.2

1.9

1.15

1.41

g/l

3.31

941

2301

Multiple myeloma and malignant plasma cell neoplasms

762

747

18.13

307.65

6.1

1.7

0.84

1.69

g/l

4.47

645

675

Certain infectious and parasitic diseases

5300

11886

2.33

307.65

2.0

1.7

1.27

1.31

g/l

0.57

4845

10886

Dentinal caries

1459

4611

3.47

307.65

2.3

1.8

1.25

1.34

g/l

0.83

1334

4200

Other diseases of blood and blood-forming organs, wide

1693

4485

4.38

307.65

2.4

1.8

1.29

1.36

g/l

0.52

1555

4097

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4508

16776

1.90

303.92

2.1

1.8

1.23

1.34

g/l

2.50

4129

15332

Kela reimbursement Agammaglobulinemia (D80-84)

235

157

65.47

302.47

5.5

1.6

1.00

1.56

g/l

1.17

203

149

Mucosal proctocolitis

936

2582

4.14

301.55

2.1

1.8

1.25

1.31

g/l

0.45

882

2378

Hepatic failure, not elsewhere classified

400

530

10.46

301.43

1.9

1.8

1.50

1.40

g/l

0.24

372

486

Neurological diseases, wide definition

1635

2766

3.11

301.39

1.9

1.8

1.22

1.33

g/l

1.19

1528

2560

Nonhereditary hypogammaglobulinemia

259

205

38.61

300.23

4.9

1.6

1.08

1.53

g/l

1.07

226

191

Other heart diseases

2470

7179

2.39

298.38

1.9

1.24

1.35

g/l

1.43

2276

6635

Colitis, primary sclerosing, strict definition

256

200

35.51

297.14

3.5

1.5

1.22

1.21

g/l

0.03

250

188

ILD, hospital admissions 3, with pneumonia sepsis

591

1174

5.97

291.81

2.3

1.8

1.09

1.46

g/l

3.51

551

1060

Diseases of the skin and subcutaneous tissue

4867

13540

1.86

291.56

1.9

1.8

1.28

1.30

g/l

0.22

4449

12372

Other specified/unspecified arthritis

1467

5360

2.95

290.50

1.9

1.24

1.36

g/l

1.51

1366

4855

Other special examinations and investigations of persons without complaint or reported diagnosis

3265

7991

2.14

289.91

1.9

1.26

1.30

g/l

0.45

3008

7308

Persons encountering health services for specific procedures and health care

5064

17940

1.81

289.49

2.0

1.8

1.20

1.33

g/l

4.35

4609

16429

Secondary and unspecified malignant neoplasm of lymph nodes

673

1517

5.35

288.41

2.9

1.9

1.17

1.43

g/l

1.38

628

1369

Heart failure,strict

2291

7224

2.42

288.27

1.9

2.0

1.21

1.40

g/l

3.16

2107

6480

Heart failure and antihypertensive medication

1346

2924

3.28

287.69

2.0

2.1

1.18

1.48

g/l

4.04

1246

2647

Asthma, hospital admissions , main diagnosis only

3925

19072

1.92

287.26

1.8

1.9

1.27

1.32

g/l

0.54

3628

17381

Tumor necrosis factor alpha inhibitors

1024

3100

3.76

286.80

1.6

1.8

1.25

1.27

g/l

0.25

962

2869

Acute sinusitis

2585

11361

2.23

285.27

2.2

1.7

1.25

1.32

g/l

1.08

2371

10435

Other soft tissue disorders, not elsewhere classified

4342

14705

1.89

285.26

1.9

1.25

1.32

g/l

1.20

3953

13462

Ulcerative colitis, NAS

971

2862

3.83

282.48

2.0

1.8

1.26

1.35

g/l

0.74

908

2635

Oxycodone

1685

6441

2.69

281.92

2.6

1.8

1.15

1.39

g/l

3.31

1505

5842

Hypertension, essential

3665

10848

2.00

279.54

1.7

2.0

1.19

1.38

g/l

6.17

3347

9967

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1098

3515

3.49

279.23

2.0

1.8

1.25

1.30

g/l

0.45

1036

3243

Asthma, including avohilmo

5459

18651

1.75

278.96

1.8

1.9

1.28

1.31

g/l

0.55

5039

16999

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

193

100

89.94

278.73

13.2

1.3

14.75

1.14

g/l

29.74

185

Persons encountering health services in other circumstances, wide

5590

17077

1.75

276.73

1.9

1.8

1.24

1.32

g/l

1.77

5178

15517

Endocrine, nutritional and metabolic diseases

3991

10758

1.95

276.49

1.8

1.9

1.19

1.38

g/l

7.73

3675

9940

Ulcerative colitis (strict definition, require KELA)

1120

3648

3.42

276.39

2.0

1.8

1.25

1.31

g/l

0.65

1054

3368

Crohn disease

926

2692

3.90

275.60

1.9

1.8

1.28

1.34

g/l

0.41

872

2473

Agranulocytosis

800

2119

4.40

275.03

2.7

1.9

1.15

1.38

g/l

2.08

750

1938

Other and unspecified iron deficiency

1639

6506

2.70

274.92

2.0

1.8

1.32

1.36

g/l

0.31

1489

5884

Bronchiectasis

615

1337

5.52

274.82

2.1

1.9

1.11

1.45

g/l

3.75

580

1189

Other acute lower respiratory infections

2586

11837

2.19

274.19

2.2

1.8

1.30

1.32

g/l

0.18

2361

10797

Gout

1306

4172

3.07

272.80

2.2

2.0

1.30

1.44

g/l

0.75

1197

3732

Chronic periapical parodontitis

1196

4063

3.22

272.36

2.6

1.8

1.23

1.38

g/l

1.19

1094

3697

Codeine or tramadol medication

5273

17075

1.77

272.04

1.8

1.26

1.33

g/l

1.60

4815

15583

Gastro-oesophageal reflux disease

3100

14032

2.04

271.81

1.9

1.33

1.31

g/l

0.20

2799

12800

Cough

1995

8324

2.43

269.89

1.9

1.13

1.35

g/l

7.97

1839

7571

Pain in throat and chest

3831

12550

1.93

268.49

1.8

1.25

1.33

g/l

1.55

3490

11465

Diseases of pulp and periapical tissues

1794

7506

2.54

268.06

2.4

1.8

1.27

1.34

g/l

0.62

1629

6850

Other specific joint derangements/joint disorders

3425

11971

1.99

267.17

1.7

1.9

1.26

1.32

g/l

1.27

3125

10976

Intestinal infectious diseases

4323

19086

1.82

266.22

2.0

1.8

1.25

1.31

g/l

1.00

3943

17451

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1168

3989

3.24

265.00

2.0

1.8

1.24

1.30

g/l

0.48

1101

3680

Malignant immunoproliferative diseases

208

136

42.08

264.63

12.5

1.3

13.72

1.12

g/l

28.55

199

127

Chronic sinusitis

2167

9879

2.32

264.29

2.0

1.9

1.16

1.35

g/l

5.97

1988

9039

Oedema, not elsewhere classified

1418

5334

2.81

260.54

1.8

1.26

1.40

g/l

1.56

1272

4786

Other necrotizing vasculopathies (FG)

475

867

6.64

258.48

2.0

1.9

0.97

1.41

g/l

3.65

442

773

Other diseases of pleura

2040

8050

2.38

257.70

2.0

1.9

1.25

1.37

g/l

1.09

1859

7238

Neoplasms

3678

10480

1.94

255.72

2.1

1.5

1.34

1.18

g/l

3.31

3405

9647

Abdominal and pelvic pain

4605

13143

1.81

255.70

1.9

1.8

1.25

1.30

g/l

0.65

4239

11989

Seropositive rheumatoid arthritis, strict definition

968

3033

3.59

255.62

1.8

1.9

1.20

1.39

g/l

2.56

907

2749

Hypothyroidism (congenital or acquired)

1290

2465

3.16

255.13

1.8

1.6

1.20

1.26

g/l

0.93

1183

2304

Osteopathies and chondropathies

2565

11985

2.13

253.47

2.3

1.8

1.27

1.33

g/l

0.82

2296

10910

Hypertensive diseases

3708

11293

1.93

253.00

1.8

2.0

1.20

1.37

g/l

5.45

3389

10382

Hypertension

3700

11281

1.92

251.42

1.7

2.0

1.20

1.37

g/l

5.41

3380

10372

Parasetamol

3801

10446

1.92

250.69

1.8

1.26

1.36

g/l

1.49

3500

9571

Hypothyroidism and >3 levothyroxin purchases

1271

2446

3.14

248.99

1.8

1.6

1.19

1.26

g/l

1.08

1166

2286

Hypothyroidism, levothyroxine purchases

1271

2446

3.14

248.99

1.8

1.6

1.19

1.26

g/l

1.08

1166

2286

Nephropathy related operations

822

2370

3.97

248.79

2.4

1.9

1.14

1.30

g/l

1.42

766

2155

Gout, FINNGEN

1306

4864

2.88

248.61

2.2

1.9

1.30

1.42

g/l

0.67

1197

4352

Other necrotizing vasculopathies

544

1166

5.61

247.32

2.0

1.8

0.98

1.42

g/l

4.94

507

1046

Complications of surgical and medical care, not elsewhere classified

4352

18063

1.79

246.39

1.9

1.26

1.33

g/l

1.15

3969

16471

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5007

17020

1.73

242.18

1.9

1.8

1.26

1.32

g/l

0.92

4653

15472

Other heart diseases, wide

4262

15174

1.80

241.00

1.9

1.8

1.27

1.31

g/l

0.50

3907

13892

Undetermined asthma, excluding more controls

708

1859

4.18

240.78

2.1

1.7

1.16

1.46

g/l

3.39

657

1684

Viral hepatitis, IBD co-morbidity

393

634

7.10

238.85

1.4

1.9

1.62

1.39

g/l

1.11

364

574

Acute bronchitis

1962

8771

2.31

237.88

2.3

1.8

1.31

1.32

g/l

0.09

1782

7957

Bacterial pneumoniae

1839

7183

2.39

236.40

2.2

1.8

1.17

1.37

g/l

4.09

1665

6509

Other disorders of white blood cells

483

980

6.13

236.10

2.1

1.8

1.44

1.41

g/l

0.07

431

901

Bacterial pneumonia (organism specified)

2034

8550

2.28

236.04

2.2

1.8

1.16

1.36

g/l

4.61

1845

7732

Glomerular diseases

1051

3616

3.21

235.24

2.4

1.9

1.19

1.35

g/l

1.33

964

3299

Other disorders of fluid, electrolyte and acid-base balance

1398

5340

2.69

233.29

1.9

1.25

1.46

g/l

2.51

1257

4803

Cholelithiasis, broad definition with cholecystitis

3751

14451

1.84

232.44

1.9

1.33

1.34

g/l

0.06

3408

13145

Diseases of the respiratory system

2895

7280

2.06

232.10

1.9

1.7

1.31

1.39

g/l

0.76

2665

6627

Chronic lymphocytic leukaemia, helper endpoint

289

358

11.08

229.69

2.0

1.3

1.15

1.19

g/l

0.06

249

330

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

289

358

11.08

229.69

2.0

1.3

1.15

1.19

g/l

0.06

249

330

Secondary uncertain malignant neoplasm

776

2261

3.87

229.65

2.8

1.8

1.22

1.38

g/l

0.85

718

2032

Malignant immunoproliferative diseases

208

178

31.71

228.95

12.5

1.4

13.72

1.12

g/l

28.53

199

159

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2151

6309

2.26

228.17

1.9

1.25

1.41

g/l

3.72

1989

5812

Type 2 diabetes, wide definition

3463

12420

1.89

228.10

1.7

2.0

1.15

1.37

g/l

8.62

3139

11304

Depression medications

1445

2683

2.82

228.02

1.8

1.6

1.30

1.25

g/l

0.48

1342

2502

Undetermined asthma

708

1947

3.99

225.41

2.1

1.7

1.16

1.45

g/l

3.27

657

1769

Diarrhoea and gastroenteritis of presumed infectious origin

3189

15911

1.89

225.09

2.0

1.8

1.27

1.31

g/l

0.54

2919

14554

Dermatitis

2743

14457

1.98

224.61

2.0

1.9

1.38

1.32

g/l

0.66

2506

13170

Erysipelas

2245

9996

2.14

224.45

1.8

1.9

1.29

1.37

g/l

0.92

2029

9037

Covid-19 confirmed case

1463

6070

2.59

224.03

2.4

1.8

1.33

g/l

0.00

1358

5545

Heart failure, strict

2390

8474

2.13

223.33

1.9

2.0

1.21

1.39

g/l

3.03

2194

7588

Hernia of abdominal wall, postoperative

738

2088

3.78

223.12

1.8

1.6

1.43

1.41

g/l

0.06

669

1907

Diffuse large B-cell lymphoma, helper endpoint

374

635

7.46

221.46

3.4

1.4

1.19

1.15

g/l

0.14

353

575

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

374

635

7.46

221.46

3.4

1.4

1.19

1.15

g/l

0.14

353

575

Other and unspecified dermatitis

2347

11801

2.09

221.13

2.0

1.9

1.39

1.31

g/l

0.71

2144

10757

Diseases of the digestive system

2069

9909

2.19

221.10

1.8

1.9

1.27

1.36

g/l

1.04

1889

8993

Abnormal results of function studies

621

1606

4.50

220.72

1.8

1.9

1.24

1.38

g/l

1.03

557

1465

Neurological diseases

4130

11954

1.79

220.18

1.9

1.8

1.27

1.32

g/l

0.77

3827

10950

Cholelithiasis

3583

14224

1.83

217.93

1.9

1.34

1.35

g/l

0.04

3261

12931

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

808

2494

3.59

217.12

2.7

1.5

1.16

1.18

g/l

0.07

755

2260

Hypothyroidism, strict autoimmune

2858

9925

1.97

216.86

1.7

1.8

1.23

1.36

g/l

2.73

2573

8956

Mixed connective tissue disease

522

1208

5.20

216.65

2.0

1.8

1.45

1.43

g/l

0.06

494

1101

Dermatitis and eczema

4807

19322

1.68

215.43

1.9

1.8

1.36

1.29

g/l

1.02

4400

17644

Other specified/unspecified systemic involvement of connective tissue

475

1023

5.61

215.15

1.9

1.8

1.46

1.39

g/l

0.27

446

927

Bacterial pneumonia, not elsewhere classified

1708

6741

2.36

214.02

2.1

1.8

1.19

1.37

g/l

3.12

1548

6102

Obesity related asthma

1624

7204

2.40

213.09

1.8

1.9

1.18

1.35

g/l

3.02

1494

6555

Other disorders of skin and subcutaneous tissue

2951

14772

1.90

212.66

2.0

1.9

1.29

1.34

g/l

0.51

2674

13413

All-cause Heart Failure

2324

8334

2.10

211.25

1.9

2.0

1.20

1.39

g/l

3.39

2136

7458

Osteoporosis

1180

4333

2.79

209.07

2.4

1.8

1.28

1.42

g/l

1.15

1044

3874

Pain in limb

3426

14059

1.82

207.89

1.9

1.27

1.33

g/l

0.85

3107

12860

SLE (Finngen)

304

446

8.50

205.86

1.9

1.7

1.31

1.50

g/l

0.59

279

399

Antihypertensive medication - note that there are other indications

2913

8450

1.95

205.46

1.7

1.9

1.24

1.34

g/l

1.96

2714

7783

Pain, not elsewhere classified

1231

4936

2.64

200.91

2.0

1.8

1.27

1.35

g/l

0.57

1146

4480

Arthropathies

4135

12431

1.74

200.83

1.8

1.9

1.27

1.32

g/l

0.77

3816

11396

Nausea and vomiting

1241

4914

2.63

200.28

2.2

1.9

1.32

1.34

g/l

0.07

1140

4464

Other gastritis (incl. Duodenitis)

1110

4256

2.80

200.09

1.9

1.39

1.36

g/l

0.15

1015

3840

Other noninfective gastroenteritis and colitis

1256

5126

2.62

198.83

2.1

1.8

1.23

1.33

g/l

0.82

1162

4677

All influenza

1196

4768

2.67

198.41

2.6

1.7

1.23

1.33

g/l

0.68

1082

4361

Low back pain

3207

13996

1.82

197.77

1.8

1.31

1.33

g/l

0.25

2905

12813

Diseases of the musculoskeletal system and connective tissue

2561

6545

2.02

197.22

1.8

1.32

1.29

g/l

0.23

2374

6007

Benign neoplasm of colon, rectum, anus and anal canal

2237

8046

2.07

196.05

1.9

1.5

1.44

1.21

g/l

3.36

2045

7311

Other diseases of biliary tract

546

1398

4.47

195.63

2.3

1.9

1.27

1.42

g/l

0.97

507

1257

Pain (limb, back, neck, head abdominally)

3295

9183

1.85

195.15

1.9

1.8

1.27

1.33

g/l

0.88

3037

8399

Asthma/COPD (KELA code 203)

4144

17753

1.69

194.56

1.8

1.9

1.26

1.32

g/l

1.00

3810

16187

Bleeding

3474

14703

1.78

193.90

1.9

1.40

1.30

g/l

1.25

3125

13393

Chronic lymphocytic leukaemia

289

437

9.00

193.84

2.0

1.8

1.15

1.51

g/l

0.69

249

397

Malignant neoplasm, wide definition for exclusion

3867

13561

1.74

192.41

2.4

1.6

1.44

1.22

g/l

3.86

3557

12427

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

3867

13561

1.74

192.39

2.4

1.6

1.44

1.22

g/l

3.86

3557

12427

Provisional assignment of new diseases of uncertain etiology

2077

10518

2.07

191.96

2.3

1.8

1.35

1.29

g/l

0.47

1932

9641

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

331

571

7.16

191.89

3.4

1.4

1.66

1.19

g/l

1.73

316

517

Codes for special purposes

2079

10534

2.07

191.84

2.3

1.8

1.35

1.29

g/l

0.46

1934

9655

Adalimumab

634

1831

3.97

191.68

1.6

1.9

1.25

1.29

g/l

0.36

594

1697

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

3863

13564

1.74

191.35

2.4

1.6

1.44

1.22

g/l

3.83

3553

12431

Explicit bacterial Sepsis

600

1670

4.01

189.33

2.4

1.9

1.26

1.41

g/l

0.57

542

1513

Other nutritional deficiencies

2843

15613

1.85

188.93

1.7

1.9

1.16

1.33

g/l

8.37

2595

14332

General examination and investigation of persons without complaint and reported diagnosis

2797

7986

1.92

188.59

1.8

1.9

1.25

1.30

g/l

0.61

2589

7305

Haemorrhage from respiratory passages

1454

5966

2.37

187.52

2.1

1.9

1.56

1.37

g/l

1.30

1327

5384

Dorsalgia

4380

14557

1.67

187.33

1.8

1.27

1.33

g/l

0.81

3990

13327

Other Crohn's disease

518

1324

4.54

187.00

1.8

1.23

1.33

g/l

0.65

492

1228

Ulcerative colitis (strict definition, all Crohn cases excluded)

862

3022

3.13

186.40

2.0

1.8

1.25

1.31

g/l

0.47

814

2784

Diffuse large B-cell lymphoma

374

749

6.28

186.17

3.4

1.8

1.19

1.56

g/l

1.45

353

673

Deposits [accretions] on teeth

526

1316

4.49

184.76

2.7

1.7

1.09

1.31

g/l

1.45

481

1204

Streptococcal septicaemia

508

1290

4.46

183.37

2.4

1.9

1.32

1.41

g/l

0.25

462

1177

Other antidepressants

4540

14733

1.65

182.61

1.8

1.9

1.26

1.31

g/l

0.81

4106

13511

Complications of medical and surgical care

3071

16900

1.79

182.05

1.9

1.27

1.34

g/l

1.04

2799

15387

Malignant neoplasm

3835

13680

1.71

181.67

2.5

1.6

1.48

1.22

g/l

4.54

3503

12544

Non-allergic asthma (mode), excluding more controls

873

3062

3.00

181.49

1.9

1.7

1.31

1.41

g/l

0.50

824

2762

Sleep disorders (combined)

4267

17396

1.65

180.88

1.8

1.9

1.19

1.34

g/l

5.73

3867

15943

Glomerular disorders in diseases classified elsewhere

684

2143

3.57

180.56

2.6

1.9

1.15

1.39

g/l

1.65

624

1952

Other demyelinating diseases of the central nervous system

352

686

6.45

180.51

3.2

1.7

1.18

1.39

g/l

0.88

346

637

Benign neoplasm: Colon

1933

7351

2.10

179.12

1.8

1.5

1.39

1.22

g/l

2.19

1765

6653

Myeloid leukaemia

256

368

9.25

178.83

1.6

1.3

1.16

1.15

g/l

0.04

244

339

Asthma and opportunity respiratory infection

375

778

5.95

178.55

2.1

1.8

1.05

1.51

g/l

3.22

352

700

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

281

442

7.81

178.00

1.9

1.3

1.39

1.14

g/l

0.84

258

403

Other bacterial intestinal infections

903

3330

2.93

176.29

2.0

1.8

1.15

1.37

g/l

2.91

807

3023

Cardiac arrhythmias

2723

9960

1.87

176.23

1.8

1.9

1.27

1.37

g/l

1.36

2498

9153

6-mercaptopurine

280

446

7.83

175.86

2.0

1.7

1.21

1.34

g/l

0.58

261

409

Atrial fibrillation and flutter

1400

3969

2.41

173.59

1.7

1.9

1.20

1.45

g/l

3.55

1290

3630

Other (seronegative) rheumatoid arthritis, wide

982

3817

2.79

173.39

1.8

1.9

1.22

1.39

g/l

2.49

898

3444

Persons encountering health services for examination and investigation

2876

7991

1.85

172.29

1.8

1.9

1.31

1.30

g/l

0.03

2645

7308

Unspecified kidney failure

519

1399

4.13

171.39

2.2

1.8

1.05

1.49

g/l

4.02

475

1245

Complications of procedures, not elsewhere classified

3344

17359

1.72

170.80

1.8

1.9

1.26

1.34

g/l

1.47

3050

15817

Early onset COPD, excluding more controls

864

3159

2.90

169.42

1.9

1.8

1.21

1.42

g/l

2.20

791

2857

Symptoms and signs involving the skin and subcutaneous tissue

2916

16957

1.77

169.30

2.1

1.8

1.34

1.32

g/l

0.15

2720

15417

Anxiety disorders, excluding more controls

3605

14494

1.70

169.18

1.9

1.30

1.29

g/l

0.11

3291

13319

Polyneuropathies and other disorders of the peripheral nervous system

1032

4157

2.67

168.93

2.5

1.8

1.56

1.34

g/l

1.43

927

3746

Non-allergic asthma (mode)

873

3184

2.88

168.74

1.9

1.7

1.31

1.40

g/l

0.41

824

2890

Viral infections characterized by skin and mucous membrane lesions

1876

9640

2.04

166.12

2.5

1.8

1.32

1.33

g/l

0.05

1730

8821

Other and unspecified disorders of white blood cells

343

703

6.04

165.79

2.3

1.8

1.58

1.48

g/l

0.18

303

649

Spondylopathies

3323

11988

1.73

165.46

1.8

1.9

1.18

1.35

g/l

5.16

3018

10932

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

274

459

7.61

164.74

3.1

1.4

0.87

1.16

g/l

2.05

248

425

Episodal and paroxysmal disorders

4858

16136

1.58

163.46

1.8

1.9

1.25

1.34

g/l

1.84

4447

14758

Bacterial intestinal infections, IBD co-morbidities

900

3461

2.80

161.93

2.0

1.8

1.18

1.36

g/l

1.83

805

3142

Insulin medication

2510

12094

1.84

161.31

1.7

2.0

1.17

1.36

g/l

5.72

2274

11030

Disorders of mineral metabolism

496

1361

4.13

160.93

2.4

2.0

1.13

1.44

g/l

2.66

440

1244

Disorders of thyroid, IBD co-morbidities

743

1789

3.17

160.32

1.8

1.9

1.23

1.42

g/l

1.79

680

1629

Lower back pain or/and sciatica

4285

19098

1.60

159.86

1.8

1.9

1.28

1.32

g/l

0.57

3887

17463

Alcohol use disorder, Swedish definition

2348

12130

1.86

159.74

1.6

1.9

1.41

1.29

g/l

2.08

2116

11125

Seronegative rheumatoid arthritis

618

1961

3.45

158.17

1.8

1.9

1.15

1.40

g/l

3.29

573

1755

Diseases of the eye and adnexa

3739

11486

1.67

157.25

1.9

1.7

1.26

1.28

g/l

0.20

3460

10574

2452

12746

1.83

157.08

1.6

1.9

1.41

1.29

g/l

2.18

2204

11690

Persons encountering health services in other circumstances

1685

8499

2.07

156.82

1.9

1.8

1.30

1.31

g/l

0.11

1573

7725

Fungal Sepsis

304

589

6.38

156.33

2.2

1.7

1.15

1.59

g/l

1.94

274

539

Infections of the skin and subcutaneous tissue

2486

14152

1.81

156.19

1.9

1.8

1.30

1.28

g/l

0.18

2271

12977

Soft tissue disorders

4492

15022

1.59

156.10

1.7

1.9

1.23

1.31

g/l

1.75

4119

13751

Other and unspecified types of non-Hodgkin lymphoma, hilmo

331

694

5.84

155.49

3.4

1.8

1.66

1.55

g/l

0.20

316

634

Selective deficiency of immunoglobulin G [IgG] subclasses

148

135

25.56

155.06

4.1

1.7

1.05

1.43

g/l

0.90

138

126

Myeloid leukaemia

256

430

7.86

154.76

1.6

1.7

1.16

1.46

g/l

0.87

244

395

Disorders of other endocrine glands

1907

9922

1.97

154.60

2.0

1.8

1.22

1.33

g/l

1.63

1754

9066

Other joint disorders

3747

12358

1.65

153.83

1.8

1.9

1.31

1.32

g/l

0.16

3431

11325

Implicit fungal Sepsis

286

535

6.68

153.12

2.2

1.7

1.16

1.61

g/l

1.81

258

492

Benign neoplasms

3268

11110

1.71

152.96

1.9

1.6

1.29

1.21

g/l

1.70

3001

10220

Chronic periodontitis

760

2765

2.99

152.86

2.2

1.8

1.27

1.41

g/l

0.64

691

2491

Diabetes, varying definitions

4307

16616

1.59

152.76

1.7

1.9

1.20

1.34

g/l

4.96

3908

15222

Diabetes mellitus

4325

16691

1.59

152.28

1.7

1.9

1.20

1.34

g/l

5.17

3926

15290

Obesity and other hyperalimentation

2620

15150

1.77

152.26

1.7

1.9

1.15

1.34

g/l

9.97

2390

13903

Idiopathic thrombocytopenic purpura

283

530

6.84

152.24

2.4

1.6

1.31

1.46

g/l

0.36

260

488

Viral pneumonia

654

2199

3.24

151.74

3.0

1.8

1.39

1.35

g/l

0.11

601

2019

Type 2 diabetes

4068

15417

1.61

151.50

1.6

2.0

1.22

1.36

g/l

3.62

3681

14106

Sleep apnoea

3801

16316

1.63

151.24

1.8

1.9

1.17

1.34

g/l

6.10

3433

14940

Insulin, combination of fast acting with intermediate-acting or long-acting

2511

13344

1.79

151.08

1.7

1.9

1.17

1.35

g/l

5.12

2275

12150

Systemic lupus erythematosus

304

608

6.16

150.85

1.9

1.8

1.31

1.36

g/l

0.17

279

557

Obesity

2603

15083

1.77

150.55

1.6

1.9

1.15

1.34

g/l

9.70

2373

13839

Sleep apnoea, including avohilmo

4021

16734

1.60

149.79

1.8

1.9

1.17

1.35

g/l

6.96

3649

15313

Non-Hodgkin lymphoma, all

299

594

6.09

148.80

3.8

1.8

2.50

1.58

g/l

1.78

276

534

Follicular lymphoma

312

645

5.86

148.48

2.4

1.4

0.92

1.23

g/l

2.83

294

581

2540

13211

1.78

148.22

1.6

1.9

1.40

1.29

g/l

1.89

2285

12127

Diseases of arteries, arterioles and capillaries (FINNGEN)

1029

2942

2.57

148.15

1.9

2.0

1.20

1.52

g/l

4.06

946

2686

Other disorders of teeth and supporting structures

988

4137

2.54

147.89

2.1

1.8

1.39

g/l

0.00

901

3745

Anxiety disorders

3834

17358

1.61

147.56

1.9

1.8

1.30

g/l

0.03

3500

15925

Care involving dialysis

490

1419

3.92

147.15

2.2

1.9

1.03

1.38

g/l

3.31

452

1303

Enterocolitis due to Clostridium difficile

566

1783

3.50

147.13

2.0

1.9

1.14

1.42

g/l

2.38

508

1601

Cerebrovascular diseases (FINNGEN)

1318

4325

2.28

147.10

1.8

1.9

1.15

1.46

g/l

6.66

1198

3965

Mood disorders, excluding more controls

3968

15453

1.60

146.74

1.8

1.9

1.29

1.31

g/l

0.16

3593

14178

Neurotic, stress-related and somatoform disorders

3800

17248

1.61

146.66

1.9

1.8

1.30

g/l

0.02

3470

15823

Other dorsopathies, not elsewhere classified

4292

14649

1.58

146.53

1.8

1.29

1.33

g/l

0.45

3936

13414

Constipation

3567

16082

1.63

146.48

2.0

1.9

1.27

1.33

g/l

0.69

3207

14701

Allergic asthma (mode), excluding more controls

1005

4162

2.48

145.39

1.7

1.21

1.35

g/l

2.17

933

3829

Vocal cord dysfunction

580

1703

3.35

144.53

2.1

1.9

1.28

1.46

g/l

1.15

532

1559

Acute tubulo-interstitial nephritis

2412

12326

1.79

144.14

1.9

1.8

1.32

1.36

g/l

0.36

2184

11182

Crohn's disease NAS

447

1237

4.13

143.93

2.0

1.8

1.28

1.37

g/l

0.47

420

1145

Noninfectious colitis NAS

716

2611

2.98

143.51

2.0

1.9

1.32

1.38

g/l

0.25

660

2387

Unspecified jaundice

332

738

5.19

143.04

1.9

1.43

1.64

g/l

0.46

301

661

Other and unspecified polyneuropathies, also in other diseases

878

3554

2.66

142.35

2.5

1.8

1.51

1.35

g/l

0.87

781

3194

Acquired haemolytic anaemia

234

391

7.92

142.28

2.7

1.6

1.68

1.58

g/l

0.16

215

359

Non-ischemic cardiomyopathy

1205

4517

2.31

141.16

2.1

1.9

1.34

1.44

g/l

0.54

1108

4012

Diverticular disease of intestine

2761

10882

1.74

140.74

2.0

1.9

1.37

1.36

g/l

0.04

2512

9885

Obesity due to excess calories

1983

10965

1.88

140.16

1.6

1.9

1.14

1.34

g/l

8.10

1808

10081

Disorders of lipoprotein metabolism and other lipidaemias

3175

12266

1.67

139.91

1.7

1.9

1.14

1.38

g/l

8.47

2854

11188

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3950

15600

1.59

139.82

1.6

2.0

1.21

1.34

g/l

3.08

3590

14284

Idiopathic pulmonary fibrosis

426

1160

4.15

139.76

2.3

1.9

1.09

1.52

g/l

3.13

398

1036

Other diseases of the digestive system

1301

6248

2.19

139.09

1.7

1.9

1.37

g/l

0.02

1195

5618

Allergic asthma (mode)

1005

4246

2.43

139.06

1.7

1.21

1.34

g/l

1.91

933

3918

Depression

4008

18046

1.57

138.15

1.8

1.9

1.29

1.30

g/l

0.16

3637

16547

Diagnoses used for exclusion with ILD

1136

5203

2.31

137.78

1.8

1.20

1.36

g/l

2.06

1039

4705

Dorsopathies

4400

14793

1.55

137.46

1.8

1.26

1.33

g/l

1.18

4049

13549

GI-bleeding

1293

6227

2.18

137.09

1.7

1.9

1.37

1.38

g/l

0.04

1186

5596

Mycoses

1197

5625

2.26

136.50

2.1

1.8

1.27

1.34

g/l

0.38

1077

5136

Factors influencing health status and contact with health services

1378

3197

2.23

136.07

1.9

1.8

1.36

1.32

g/l

0.18

1277

2935

Direct fill therapy

752

2900

2.83

135.85

2.4

1.8

1.21

1.31

g/l

0.82

690

2674

Diseases of oral cavity, salivary glands and jaws

3796

12445

1.60

135.81

1.9

1.8

1.25

1.33

g/l

1.32

3493

11340

Common variable immunodeficiency

128

114

25.31

135.70

5.0

1.7

0.92

1.52

g/l

0.84

104

109

Glucagon-like peptide-1 (GLP-1) analogues

2154

10039

1.83

135.58

1.6

2.1

1.20

1.39

g/l

2.70

1926

9080

Spondyloarthritis

825

3307

2.65

135.26

1.7

1.8

1.29

1.39

g/l

0.75

777

3005

Nonalcoholic steatohepatitis

143

150

19.37

135.22

1.5

1.6

1.27

1.64

g/l

0.62

129

136

Chronic rhinitis, nasopharyngitis and pharyngitis

1416

7096

2.09

135.12

1.8

1.9

1.16

1.36

g/l

5.10

1287

6495

Symptoms and signs concerning food and fluid intake

511

1590

3.50

134.63

1.8

1.9

1.15

1.39

g/l

2.43

466

1430

SLE, ICD10

291

620

5.78

134.47

1.9

1.7

1.32

1.35

g/l

0.09

267

570

SLE, strict definition

291

620

5.78

134.47

1.9

1.7

1.32

1.35

g/l

0.09

267

570

Rare circulating lymphoid malignancy

274

557

6.21

134.46

3.1

1.8

0.87

1.51

g/l

3.49

248

514

Cytomegalovirus infection, IBD co-morbidity

232

410

7.65

134.15

2.4

1.6

1.28

1.40

g/l

0.31

207

380

Mood disorders

4265

18649

1.54

134.04

1.8

1.9

1.29

1.31

g/l

0.18

3869

17070

Mood [affective] disorders

4256

18634

1.54

133.86

1.8

1.9

1.29

1.31

g/l

0.17

3860

17059

Benign neoplasm of colon, rectum, anus and anal canal

2345

12389

1.77

133.44

1.9

1.43

1.33

g/l

0.88

2143

11166

Other disorders of lacrimal gland

1463

7457

2.06

133.39

2.2

1.9

1.31

1.35

g/l

0.32

1336

6785

Chronic gastritis

1127

5204

2.28

133.30

1.8

1.9

1.30

1.34

g/l

0.32

994

4672

Atrial fibrillation and flutter with reimbursement

1065

2954

2.42

132.67

1.8

2.0

1.19

1.53

g/l

3.94

987

2677

Gout, idiopatic and unspecified

997

4405

2.40

132.11

1.6

2.0

1.18

1.41

g/l

1.87

917

3931

Irritable bowel syndrome

1216

5830

2.19

130.79

1.7

1.8

1.21

1.39

g/l

3.14

1098

5322

Hypothyroidism, drug reimbursement

622

1489

3.14

130.75

1.9

1.6

1.30

1.31

g/l

0.04

565

1398

Other disorders of urethra and urinary system

2782

12721

1.69

130.47

1.9

1.28

1.37

g/l

1.38

2538

11569

Other functional intestinal disorders

1774

9195

1.90

130.08

2.0

1.8

1.22

1.35

g/l

1.54

1605

8347

Insulin, intermediate and long-acting

2183

12438

1.78

129.33

1.6

1.9

1.17

1.35

g/l

4.14

1975

11314

Cytomegaloviral disease

233

428

7.22

129.05

2.4

1.6

1.28

1.31

g/l

0.08

208

394

Other diseases of urinary system

4201

15714

1.54

128.78

1.9

1.26

1.34

g/l

1.48

3839

14351

Valvular heart disease excluding rheumatic fever

1829

7261

1.91

128.69

2.0

1.9

1.24

1.34

g/l

1.09

1668

6550

Other immunodeficiencies

164

214

12.33

128.35

3.9

1.7

1.42

1.31

g/l

0.14

151

198

Care involving use of rehabilitation procedures

2558

14726

1.70

128.08

1.9

1.23

1.34

g/l

2.34

2353

13455

Non-rheumatic valve diseases

1810

7167

1.91

127.94

2.0

1.9

1.24

1.35

g/l

1.07

1651

6462

Depression or dysthymia

2990

10308

1.67

127.17

1.8

1.9

1.34

1.30

g/l

0.28

2721

9490

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2404

14381

1.72

126.21

1.8

1.9

1.25

1.34

g/l

1.29

2191

13085

Diabetes, insulin treatment (Kela reimbursement)

4078

16621

1.54

125.93

1.6

1.9

1.23

1.34

g/l

2.25

3704

15188

Haemolytic anaemias

280

610

5.61

125.89

2.6

1.6

1.60

1.42

g/l

0.47

257

558

Other autoimmune haemolytic anaemias

157

200

12.20

124.62

2.9

1.6

1.93

1.50

g/l

0.62

141

179

Other ulcerative colitis

384

1062

4.13

123.77

2.2

1.8

1.26

1.37

g/l

0.55

362

978

Pleural effusion

674

2568

2.82

123.43

2.0

1.8

1.28

1.41

g/l

0.60

620

2286

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

170

237

10.07

123.28

3.1

1.3

2.79

1.11

g/l

3.07

163

216

Other diseases of hard tissues of teeth

2600

11804

1.69

122.95

2.0

1.8

1.29

1.33

g/l

0.36

2390

10801

Other diseases of upper respiratory tract

4520

16004

1.50

122.85

1.9

1.22

1.34

g/l

3.25

4146

14588

Chronic hepatitis NAS

169

238

10.49

122.58

2.1

1.7

1.36

1.37

g/l

0.03

155

219

Urticaria and erythema

1597

8622

1.93

122.17

1.9

1.8

1.25

1.31

g/l

0.84

1465

7936

Type 2 diabetes, definitions combined

3741

14682

1.56

122.16

1.6

2.0

1.25

1.36

g/l

2.14

3387

13428

COPD (mode)

1052

3801

2.28

122.09

1.7

1.8

1.41

1.45

g/l

0.13

949

3398

Respiratory disorders in diseases classified elsewhere

170

243

10.35

121.77

2.5

1.8

1.15

1.62

g/l

0.78

160

224

Disorders of lacrimal system

1709

9431

1.89

121.75

2.2

1.8

1.33

1.36

g/l

0.18

1559

8558

Crohn's disease of small intestine

433

1308

3.73

121.67

1.8

1.21

1.38

g/l

1.00

408

1214

Follicular lymphoma, hilmo

312

761

4.92

121.43

2.4

1.9

0.92

1.54

g/l

4.48

294

691

Cholecystectomy

2752

15221

1.65

120.37

1.8

1.9

1.37

1.34

g/l

0.29

2518

13817

Benign neoplasms

4075

15238

1.53

120.19

1.9

1.8

1.33

1.28

g/l

0.68

3718

13956

Exposure to unspecified factor

3899

20370

1.52

119.46

1.9

1.8

1.28

1.31

g/l

0.29

3510

18675

Heart failure and bmi 25plus

1351

4676

2.08

119.28

1.9

2.0

1.20

1.36

g/l

1.60

1228

4156

Systemic lupus erythematosus, unspecified

254

536

5.85

118.87

2.0

1.7

1.29

1.36

g/l

0.26

233

495

Pneumonia due to other infectious organisms, not elsewhere classified

243

491

5.96

118.64

2.7

1.6

1.07

1.44

g/l

2.00

220

459

Gout, unspecified

828

3542

2.49

118.51

1.6

1.9

1.14

1.40

g/l

2.68

759

3155

Type 2 diabetes, strict (exclude DM1)

3745

14813

1.54

118.20

1.6

2.0

1.25

1.36

g/l

2.03

3391

13548

Continuous positive airway pressure

801

2864

2.54

118.15

1.9

2.0

1.22

1.38

g/l

1.05

707

2638

Hypo-osmolality and hyponatraemia

708

2811

2.67

117.93

1.9

1.8

1.19

1.45

g/l

3.27

639

2520

Functional dyspepsia

1111

5361

2.18

117.55

1.9

1.8

1.40

1.33

g/l

0.33

1018

4892

Diabetes medication

4150

17107

1.51

117.37

1.6

1.9

1.23

1.34

g/l

2.28

3762

15653

Benign neoplasm: Colon

1954

11093

1.79

116.93

1.8

1.9

1.38

1.34

g/l

0.29

1784

9977

Presence of other functional implants

2098

8637

1.77

116.93

2.2

1.9

1.33

1.38

g/l

0.29

1869

7747

Toxic liver disease

166

239

9.58

116.73

1.5

1.8

1.27

1.60

g/l

0.53

157

221

Psychiatric diseases

4554

15656

1.49

116.19

1.8

1.9

1.28

1.30

g/l

0.25

4123

14391

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2070

11948

1.75

116.07

1.9

1.21

1.33

g/l

2.18

1897

10923

Crohn disease (strict definition, require KELA)

420

1289

3.69

115.47

1.8

1.19

1.36

g/l

1.42

397

1200

Symptoms and signs involving the urinary system

2959

14628

1.61

115.23

2.0

1.9

1.30

1.32

g/l

0.16

2652

13322

Any mental disorder

4612

15924

1.48

115.01

1.8

1.9

1.29

1.30

g/l

0.09

4178

14614

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1504

7070

1.94

115.00

2.2

1.5

1.18

1.20

g/l

0.14

1375

6403

Cystitis

3398

13578

1.57

114.70

1.8

1.29

1.36

g/l

1.24

3108

12367

Acute pancreatitis

839

3658

2.43

114.64

2.0

1.9

1.27

1.35

g/l

0.50

777

3328

Polymyalgia rheumatica

568

2068

2.96

113.83

1.7

1.9

1.39

1.42

g/l

0.09

521

1830

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

434

1370

3.56

113.77

1.8

1.19

1.34

g/l

1.27

410

1276

Any event in cancer register

3723

14735

1.53

113.56

2.3

1.7

1.39

1.27

g/l

1.49

3390

13535

Crohn disease (strict definition, require KELA, min 2 HDR)

413

1269

3.68

113.36

1.8

1.19

1.30

g/l

1.06

393

1182

Other reaction to severe stress, and adjustment disorders

1582

8709

1.89

113.31

2.1

1.8

1.30

g/l

0.02

1480

8071

Other degenerative diseases of the nervous system

1103

3994

2.19

113.15

3.0

1.9

1.26

1.41

g/l

1.02

1025

3619

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3776

16538

1.52

112.82

1.9

1.28

1.33

g/l

0.73

3450

15065

Drug-induced neutropenia

428

1351

3.59

112.64

2.6

1.8

1.08

1.43

g/l

2.93

409

1227

Type 2 diabetes, definitions combined, including avohilmo

3734

14781

1.53

112.60

1.6

2.0

1.23

1.36

g/l

2.95

3372

13526

Gastroduodenal ulcer

981

4571

2.24

112.30

1.7

1.9

1.25

1.37

g/l

0.71

897

4074

Syncope and collapse

1530

7341

1.90

112.03

1.9

1.8

1.32

1.39

g/l

0.42

1388

6607

Substance abuse, excluding more controls

2205

11630

1.71

111.53

1.6

1.9

1.34

1.29

g/l

0.42

1992

10708

Other medical care

1538

8230

1.89

111.17

2.2

1.9

1.18

1.39

g/l

3.66

1374

7427

Anxiety (asthma-related co-morbidities)

2474

12065

1.66

111.17

1.8

1.34

1.29

g/l

0.45

2252

11171

Disorders of eyelid, lacrimal system and orbit

3282

16992

1.55

111.07

2.1

1.8

1.32

1.33

g/l

0.12

2978

15472

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

321

840

4.26

110.88

1.7

1.4

1.39

1.14

g/l

1.82

287

753

Other/unspecified cytomegaloviral diseases

198

362

7.43

110.86

2.6

1.6

1.20

1.42

g/l

0.64

179

332

Recurrent or chronic depression

1737

7020

1.85

110.83

1.8

1.30

1.31

g/l

0.05

1574

6508

Other/unspecified rheumatoid arthritis

605

2315

2.83

110.49

1.8

1.25

1.41

g/l

1.43

543

2079

Wegener granulomatosis

170

267

8.71

110.45

2.4

1.6

0.75

1.27

g/l

3.58

162

244

L04AC Interleukin inhibitors

346

972

4.12

109.77

1.7

1.8

1.24

1.31

g/l

0.38

330

908

Etanercept

402

1240

3.67

109.76

1.6

1.9

1.26

1.35

g/l

0.52

376

1145

Use of hypnotics and sedatives

4267

17021

1.48

109.67

1.9

1.8

1.27

1.32

g/l

0.91

3878

15572

Other viral diseases

1324

6951

1.99

109.66

2.2

1.8

1.36

1.28

g/l

0.74

1221

6448

Disorders of calcium metabolism

357

1018

3.95

109.57

2.6

1.9

1.16

1.46

g/l

1.83

317

919

Abnormalities of heart beat

1331

6932

1.97

109.53

1.8

1.9

1.39

1.36

g/l

0.11

1194

6276

Gout, strict definition

730

3064

2.55

109.25

1.6

1.9

1.16

1.41

g/l

1.52

666

2719

Pneumocystosis

176

294

8.50

108.73

3.1

1.7

0.98

1.44

g/l

1.85

154

272

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

194

345

6.71

108.38

2.1

1.3

1.45

1.13

g/l

0.75

175

313

Ulcer of lower limb, not elsewhere classified

605

2334

2.79

108.33

1.8

1.9

1.25

1.39

g/l

0.86

552

2094

Zoster [herpes zoster]

770

3329

2.47

107.74

2.8

1.8

1.48

1.39

g/l

0.26

694

2998

Other diseases of the respiratory system

831

3704

2.37

107.73

2.1

1.8

1.25

1.34

g/l

0.43

746

3324

Other respiratory disorders and diseases

831

3704

2.37

107.73

2.1

1.8

1.25

1.34

g/l

0.43

746

3324

Other viral hepatitis

409

1290

3.58

107.55

1.4

1.8

1.62

1.29

g/l

2.99

382

1205

Insulin, fast-acting

1489

8178

1.89

107.45

1.7

1.9

1.17

1.32

g/l

3.61

1361

7460

Secondary hypertension

382

1144

3.59

105.23

2.1

2.0

1.11

1.52

g/l

3.07

347

1046

Adrenocortical insufficiency

264

632

4.99

105.11

2.3

1.7

1.23

1.41

g/l

0.38

250

582

Genitourinary diseases

2604

8098

1.65

104.95

1.8

1.21

1.29

g/l

1.18

2412

7421

Viral hepatitis

448

1511

3.30

104.84

1.4

1.8

1.62

1.30

g/l

3.18

418

1405

Pulmonary heart disease, diseases of pulmonary circulation

1213

6293

2.01

104.59

2.3

1.8

1.18

1.37

g/l

2.09

1139

5642

Extracorporeal dialysis

368

1111

3.78

104.22

2.3

1.9

1.01

1.38

g/l

3.22

336

1028

Crohn's disease of large intestine

339

970

3.97

103.91

1.9

1.8

1.22

1.41

g/l

1.24

317

896

ILD-related respiratory insufficiency

229

495

5.60

103.70

2.5

1.8

1.11

1.57

g/l

1.79

211

445

Osteoporosis with pathological fracture (FG)

313

844

4.10

103.34

2.0

1.7

1.26

1.48

g/l

1.04

282

731

Any operation in hilmo

188

113

8.82

103.04

1.5

1.2

1.26

1.36

g/l

0.22

172

104

Fibromyalgia

460

1585

3.17

102.61

1.9

1.25

1.40

g/l

0.82

414

1463

Spondylopathies (FG)

649

2661

2.60

101.96

1.6

1.9

1.29

1.35

g/l

0.43

617

2448

Disorders of lens

2583

10301

1.63

101.95

2.0

1.9

1.29

1.33

g/l

0.32

2332

9383

Ulcerative ileocolitis

290

758

4.43

101.85

2.2

1.8

1.25

1.37

g/l

0.63

277

703

Benzodiazepine use

3908

19275

1.47

101.78

1.8

1.9

1.35

1.31

g/l

0.55

3537

17621

Collagenous colitis

467

1636

3.14

101.68

2.1

1.8

1.28

1.43

g/l

0.53

432

1486

Pure hypercholesterolaemia

2607

11121

1.61

101.32

1.7

1.9

1.14

1.40

g/l

7.84

2338

10114

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

185

336

6.55

101.08

1.8

1.3

1.68

1.19

g/l

2.35

169

301

Other disorders of adrenal gland

304

830

4.25

100.54

2.3

1.8

1.25

1.36

g/l

0.25

287

758

All anxiety disorders

2510

12870

1.61

100.21

1.8

1.34

1.30

g/l

0.36

2284

11891

Glomerulonephritis

525

1975

2.90

99.79

2.2

1.9

1.27

1.38

g/l

0.42

487

1813

Failure and rejection of transplanted organs and tissues

152

239

8.98

99.29

2.9

1.4

1.14

1.35

g/l

0.54

145

221

Myalgia

974

4773

2.14

99.03

1.9

1.31

1.38

g/l

0.55

879

4387

Hodgkin lymphoma

216

462

5.61

98.78

2.2

1.4

0.97

1.21

g/l

2.03

202

429

Migraine

1970

10122

1.70

98.57

1.7

1.8

1.25

1.33

g/l

1.31

1824

9324

Nerve, nerve root and plexus disorders

4086

17998

1.45

97.85

1.9

1.35

1.32

g/l

0.32

3736

16398

Other (not insulin) diabetes medications

3696

15312

1.49

97.74

1.6

2.0

1.23

1.35

g/l

2.48

3345

13988

Dysphagia

915

4411

2.17

96.87

2.0

1.9

1.36

1.40

g/l

0.14

838

3962

Other headache syndromes

1687

9899

1.76

96.77

1.8

1.9

1.26

1.36

g/l

1.32

1551

9060

Respiratory insufficiency

336

989

3.65

96.14

2.0

1.8

1.03

1.52

g/l

4.61

308

867

Symptoms and signs involving the nervous and musculoskeletal systems

2207

13889

1.64

96.04

2.0

1.9

1.27

1.33

g/l

0.68

2038

12637

Insulin, fast-acting or short human

1493

8495

1.82

95.72

1.7

1.9

1.17

1.31

g/l

3.23

1365

7742

Sarcoidosis

645

2726

2.55

95.69

1.8

1.17

1.34

g/l

1.90

600

2502

Systemic sclerosis (FG)

177

326

6.54

95.64

1.7

1.8

1.45

g/l

0.00

161

292

Benign neoplasm: Colon, unspecified

848

3983

2.22

94.88

1.7

1.5

1.29

1.21

g/l

0.51

760

3589

Iron deficiency anaemia secondary to blood loss (chronic)

668

2868

2.47

94.75

1.8

1.22

1.40

g/l

1.79

613

2590

Non-invasive ventilation

817

3553

2.25

94.48

1.8

2.0

1.32

1.38

g/l

0.24

724

3278

Hypokalaemia

507

1923

2.83

93.88

1.9

1.8

1.31

1.43

g/l

0.61

454

1744

Psoriatic and enteropathic arthropathies

541

2121

2.73

93.66

1.6

1.9

1.24

1.34

g/l

0.63

494

1945

Use of glatiramer acetate

166

301

7.11

92.68

3.7

1.7

0.99

1.21

g/l

2.77

160

282

Acute pancreatitis (for exclusion)

839

3997

2.22

92.44

2.0

1.9

1.27

1.35

g/l

0.52

777

3640

Gingivitis and periodontal diseases

3501

12342

1.49

92.41

1.9

1.8

1.30

1.33

g/l

0.34

3211

11244

Cutaneous abscess, furuncle and carbuncle

1074

5605

2.01

91.50

1.8

1.29

1.32

g/l

0.19

982

5167

Other/unspecified dorsalgia

1448

8229

1.81

91.27

2.0

1.9

1.24

1.34

g/l

1.24

1323

7492

Venous thromboembolism

1947

11673

1.67

91.23

2.3

1.9

1.23

1.37

g/l

1.83

1790

10532

Eosinophilic disease (BM)

141

220

8.20

90.98

1.7

1.6

1.08

1.36

g/l

0.93

129

204

Diaphragmatic hernia

1365

7699

1.84

90.50

1.9

1.40

1.36

g/l

0.18

1220

6955

Candidiasis

625

2671

2.51

90.30

2.1

1.8

1.23

1.38

g/l

1.25

564

2438

Hyperlipidaemia, other/unspecified

1345

7124

1.85

90.28

1.9

2.0

1.21

1.43

g/l

2.22

1206

6447

Urticaria

1258

6937

1.89

90.14

1.9

1.8

1.29

1.31

g/l

0.15

1151

6390

Other anxiety disorders

1832

9880

1.69

90.03

1.8

1.34

1.29

g/l

0.46

1665

9142

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2144

13634

1.62

89.23

1.8

1.9

1.26

1.34

g/l

1.08

1946

12411

Diseases of arteries, arterioles and capillaries

2354

11307

1.59

88.77

1.8

1.9

1.24

1.36

g/l

1.69

2146

10218

Asthma and allergy, excluding more controls

550

2188

2.61

88.72

1.8

1.7

1.19

1.35

g/l

1.62

509

2030

Ulcerative rectosigmoiditis

435

1579

3.00

88.43

1.8

1.21

1.31

g/l

0.65

407

1457

Other disorders involving the immune mechanism, not elsewhere classified

233

585

4.75

87.34

3.2

1.7

1.13

1.30

g/l

0.68

214

542

Disturbances of skin sensation

1128

6076

1.94

87.18

2.1

1.8

1.37

1.31

g/l

0.24

1045

5587

Disorders of sclera, cornea, iris and ciliary body

2074

13169

1.62

87.14

1.9

1.25

1.32

g/l

0.89

1921

12030

Diseases of the ear and mastoid process

4720

17392

1.40

87.00

1.9

1.8

1.29

1.30

g/l

0.07

4279

15957

Temporomandibular joint disorders

655

2885

2.38

86.89

2.0

1.8

1.26

1.38

g/l

0.81

604

2628

Polyarthrosis

755

3379

2.25

86.46

1.8

1.9

1.25

1.41

g/l

0.91

676

3023

Visual disturbances and blindness

1906

11899

1.65

86.12

2.0

1.9

1.29

1.33

g/l

0.30

1722

10827

Other disorders of skin and subcutaneous tissue, not elsewhere classified

618

2679

2.46

86.06

2.1

1.8

1.22

1.37

g/l

1.19

549

2428

Asthma and allergy

549

2216

2.57

85.88

1.8

1.7

1.20

1.34

g/l

1.48

508

2057

Diseases of salivary glands

797

3832

2.18

85.41

2.0

1.8

1.20

1.38

g/l

1.96

726

3480

DVT of lower extremities and pulmonary embolism

1487

8700

1.76

85.28

2.3

1.9

1.21

1.38

g/l

2.01

1367

7838

Other intervertebral disc disorders

3128

13092

1.49

85.09

1.8

1.9

1.31

1.34

g/l

0.25

2854

11968

Mental and behavioural disorders due to psychoactive substance use

2275

13959

1.58

85.06

1.6

1.9

1.34

1.29

g/l

0.56

2054

12800

Hereditary hypogammaglobulinemia

28.24

84.96

4.3

1.5

0.88

1.20

g/l

1.86

Benign neoplasm of other and ill-defined parts of digestive system

673

3038

2.34

84.82

1.8

1.5

1.39

1.22

g/l

0.87

626

2756

Missing teeth due to accident, extraction or parodontitis

521

2111

2.65

84.50

2.1

1.7

1.33

1.41

g/l

0.29

478

1902

Follow-up examination after treatment for conditions other than malignant neoplasms

1639

6342

1.74

84.50

1.8

1.9

1.33

1.34

g/l

0.05

1496

5778

Substance abuse

2205

13650

1.58

84.06

1.6

1.9

1.34

1.30

g/l

0.42

1992

12511

Disorders of parathyroid gland

794

3790

2.17

83.71

2.0

1.8

1.19

1.41

g/l

2.69

713

3388

Symptoms and signs involving cognition, perception, emotional state and behaviour

3654

18187

1.44

83.20

1.8

1.9

1.30

1.32

g/l

0.27

3314

16616

Drug-induced adrenocortical insufficiency

162

320

6.57

82.84

2.5

1.6

1.06

1.36

g/l

1.64

154

296

Dentofacial anomalies [including malocclusion]

1110

5973

1.91

82.55

1.9

1.7

1.19

1.33

g/l

2.03

1031

5489

COPD

1527

7464

1.74

81.84

1.8

1.9

1.36

1.37

g/l

0.04

1385

6687

Hypothyreosis and Thyroxine purchase for inclusion criteria

3513

16376

1.44

81.69

1.7

1.9

1.24

1.34

g/l

2.62

3169

14958

Intracranial trauma

2149

10303

1.59

81.69

1.8

1.31

1.33

g/l

0.10

1945

9469

Other diseases of intestine

513

2094

2.61

81.63

2.0

1.7

1.24

1.40

g/l

0.92

480

1881

Hypothyroidism, other/unspecified

3410

15824

1.45

81.40

1.7

1.9

1.22

1.35

g/l

3.56

3079

14460

Senile cataract

2258

9041

1.59

81.25

2.0

1.9

1.33

1.34

g/l

0.08

2023

8205

Papulosquamous disorders

1516

9076

1.73

81.21

1.7

1.9

1.26

1.34

g/l

0.84

1381

8290

Persons with potential health hazards related to communicable diseases

1572

9418

1.71

81.08

2.3

1.8

1.25

1.27

g/l

0.18

1480

8733

Other diseases of pericardium

252

698

4.08

80.93

2.2

1.8

1.18

1.45

g/l

1.20

229

636

Crohn disease (strict definition, all UC cases excluded)

303

947

3.59

80.81

1.6

1.8

1.13

1.34

g/l

1.47

282

879

All influenza (not pneumonia)

637

2868

2.34

80.67

2.4

1.8

1.30

1.35

g/l

0.18

581

2636

Amyloidosis

157

305

6.29

80.51

4.0

1.6

1.27

1.56

g/l

0.42

147

277

Disorders of optic nerve and visual pathways

473

1879

2.73

80.48

2.9

1.8

1.04

1.41

g/l

6.44

448

1733

Hyperkalaemia

266

764

3.85

80.30

2.0

1.9

1.28

1.56

g/l

0.73

245

682

Chronic pancreatitis

532

2229

2.55

80.26

1.6

1.9

1.19

1.36

g/l

1.46

491

2025

Abnormal findings on diagnostic imaging of other body structures

551

2346

2.51

80.23

1.9

1.8

1.16

1.38

g/l

2.53

513

2123

Visual disturbances

1772

11068

1.65

80.05

2.0

1.9

1.30

1.33

g/l

0.21

1614

10078

Hodgkin lymphoma, hilmo

216

547

4.70

80.02

2.2

1.7

0.97

1.46

g/l

2.46

202

501

Spondylosis

1910

10346

1.63

80.00

1.8

1.9

1.20

1.37

g/l

2.26

1739

9412

Defects in the complement system

102

133

12.27

79.89

3.5

1.7

1.57

1.34

g/l

0.22

127

Protozoal diseases

208

516

4.88

79.63

2.9

1.7

1.03

1.46

g/l

2.58

184

480

Acute myeloid leukaemia and myelodysplastic syndromes

142

254

6.89

79.60

1.5

1.6

1.15

1.54

g/l

0.73

136

231

Gastric ulcer

653

2982

2.29

79.53

1.8

1.27

1.37

g/l

0.41

595

2661

Chronic periodontitis, complicated

460

1817

2.76

79.45

2.1

1.8

1.15

1.37

g/l

1.69

414

1660

Sciatica+with lumbago

1863

11165

1.63

79.40

1.7

1.9

1.21

1.35

g/l

1.99

1714

10193

Pulmonary embolism

1058

5749

1.91

79.24

2.3

1.8

1.17

1.36

g/l

1.98

991

5160

Other symptoms and signs involving the digestive system and abdomen

650

2971

2.30

79.18

2.1

1.8

1.39

1.40

g/l

0.02

583

2696

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

123

194

8.13

78.67

3.0

1.2

0.96

1.10

g/l

0.42

112

179

Other overlap syndromes

154

302

6.33

78.51

2.1

1.7

1.34

1.37

g/l

0.06

148

276

Disorders of the thyroid gland

3610

16878

1.42

77.92

1.7

1.9

1.21

1.34

g/l

4.22

3272

15429

Pulmonary heart disease

1058

5782

1.90

77.83

2.3

1.8

1.17

1.36

g/l

2.04

991

5192

Herpesviral [herpes simplex] infections

537

2293

2.51

77.80

2.3

1.9

1.13

1.41

g/l

4.10

498

2102

Fall on same level

4546

18792

1.37

77.40

1.8

1.9

1.27

1.31

g/l

0.71

4109

17271

Systemic sclerosis

177

395

5.36

77.04

1.7

1.45

1.28

g/l

0.58

161

357

Amyloidosis, other/unspecified

140

257

6.85

76.81

4.3

1.6

1.30

1.60

g/l

0.35

130

234

Concussion

1824

9950

1.62

76.77

1.8

1.27

1.32

g/l

0.52

1664

9146

Other CVD (FINNGEN)

417

1211

2.86

76.43

2.3

2.0

1.35

1.69

g/l

1.12

371

1086

Exclusions for E4_PCOS_BROAD

766

3802

2.13

75.91

2.0

1.9

1.22

1.31

g/l

0.55

719

3523

Ethmoidectomy

598

2706

2.36

75.66

1.8

1.9

1.19

1.38

g/l

2.06

551

2492

Drug-induced osteoporosis with pathological fracture

139

260

6.99

75.50

2.2

1.8

1.07

1.29

g/l

0.78

130

236

Selective serotonin reuptake inhibitors

3905

14873

1.40

75.42

1.8

1.9

1.33

1.31

g/l

0.17

3528

13647

Unspecified acute lower respiratory infection

630

2909

2.29

75.25

2.2

1.8

1.27

1.33

g/l

0.28

580

2666

FESS (DNB20)

581

2605

2.38

75.21

1.8

1.9

1.19

1.37

g/l

1.81

535

2403

Optic neuritis

265

800

3.75

74.99

3.4

1.7

1.07

1.35

g/l

3.21

258

746

Other diseases of lip and oral mucosa

646

3021

2.25

74.62

2.1

1.8

1.26

1.41

g/l

1.04

587

2743

Other general symptoms and signs

260

763

3.70

74.37

1.9

1.7

1.50

1.34

g/l

0.28

238

702

Diseases of pulp and periapical tissues, including avohilmo

4235

16168

1.38

74.22

1.8

1.30

1.31

g/l

0.14

3876

14768

Other chronic obstructive pulmonary disease

1443

7193

1.72

74.20

1.8

1.9

1.37

g/l

0.01

1302

6438

Dental caries 1 and operation codes

3336

12085

1.44

73.83

1.9

1.8

1.31

1.30

g/l

0.08

3064

10992

Dental pulpitis 1

4238

16197

1.38

73.83

1.9

1.8

1.30

1.31

g/l

0.09

3883

14793

Dental pulpitis 4

4237

16191

1.38

73.78

1.9

1.8

1.30

1.31

g/l

0.09

3881

14789

Other pleural conditions

416

1620

2.75

73.13

2.1

1.8

1.28

1.44

g/l

0.52

380

1452

Psoriasis

1120

6357

1.83

73.00

1.7

1.9

1.28

1.34

g/l

0.40

1022

5831

Anaemia in chronic diseases classified elsewhere

165

363

5.41

73.00

1.8

1.6

0.98

1.45

g/l

1.42

147

334

Ulcerative enterocolitis

211

559

4.34

72.72

2.3

1.7

1.21

1.33

g/l

0.56

194

514

Convulsions, not elsewhere classified

842

4306

2.00

72.49

1.8

1.29

1.34

g/l

0.45

771

3913

Biguanides

3501

15528

1.41

72.20

1.6

2.0

1.24

1.35

g/l

2.02

3168

14188

Rheumatism, unspecified

602

2788

2.28

71.52

1.8

1.9

1.20

1.42

g/l

2.49

548

2544

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

207

552

4.42

71.39

3.1

1.7

1.07

1.32

g/l

1.37

191

512

Other diseases of pancreas

350

1270

3.00

71.34

1.7

2.0

1.22

1.49

g/l

1.32

313

1154

Other arrhythmias

2276

11687

1.52

71.15

1.9

1.30

1.34

g/l

0.39

2087

10650

Other abnormalities of plasma proteins

128

234

6.98

70.81

3.3

1.7

1.55

1.27

g/l

0.40

119

213

Hepatomegaly and splenomegaly, not elsewhere classified

106

163

8.88

70.31

2.1

1.8

1.37

1.35

g/l

0.03

148

570

2603

2.31

70.06

2.1

1.8

1.26

1.36

g/l

0.61

517

2374

Other symptoms and signs involving the nervous and musculoskeletal systems

1574

9877

1.64

69.77

2.0

1.8

1.26

1.32

g/l

0.77

1473

9006

COPD, hospital admission 2, with asthma infections

1091

5263

1.83

69.77

1.9

1.40

1.38

g/l

0.08

975

4707

Infection due to other mycobacteria

122

214

7.01

69.77

1.8

1.6

1.40

1.76

g/l

0.45

111

192

Childhood asthma (age<16), excluding more controls

529

1812

2.41

69.74

1.7

1.21

1.25

g/l

0.29

495

1699

Vasomotor and allergic rhinitis

1459

8875

1.67

68.81

1.8

1.23

1.32

g/l

1.35

1335

8176

Childhood asthma (age<16)

529

1827

2.39

68.53

1.7

1.21

1.25

g/l

0.34

495

1714

Abnormal weight loss

408

1635

2.70

68.32

1.6

1.8

1.18

1.41

g/l

1.93

376

1481

Dental caries 3 and operation codes

3476

12863

1.41

68.23

1.8

1.9

1.30

g/l

0.00

3196

11713

External causes of morbidity and mortality

2767

9590

1.47

68.03

1.9

1.28

1.31

g/l

0.27

2550

8810

Systemic sclerosis, icd10

176

433

4.85

67.86

1.7

1.8

1.45

1.28

g/l

0.63

160

393

Sequelae of external causes of morbidity and mortality

940

5179

1.89

67.76

2.1

1.9

1.25

1.36

g/l

0.84

856

4701

Chronic viral hepatitis

305

1063

3.17

67.44

1.3

1.9

1.67

1.25

g/l

4.31

281

993

Falls/tendency to fall

4410

16563

1.35

67.23

1.8

1.9

1.25

1.31

g/l

1.07

4042

15222

Early onset COPD

864

4657

1.94

66.93

1.9

1.21

1.35

g/l

1.34

791

4217

Volume depletion

357

1344

2.83

66.91

1.7

1.9

1.23

1.46

g/l

0.98

329

1208

Weight loss

436

1820

2.58

66.76

1.8

1.9

1.16

1.39

g/l

2.19

402

1647

Giant cell arteritis

219

630

3.93

66.69

1.6

1.8

1.19

1.45

g/l

0.80

201

561

Accidents

3371

12157

1.41

66.43

1.8

1.9

1.28

1.32

g/l

0.58

3097

11182

Other external causes of accidental injury

3371

12157

1.41

66.43

1.8

1.9

1.29

1.32

g/l

0.38

3090

11182

Eosinophilia

142

303

5.91

66.24

1.8

1.6

1.09

1.39

g/l

1.15

130

279

Chronic ulcer of skin, not elsewhere classified

310

1099

3.07

65.89

1.9

1.8

1.24

1.46

g/l

0.95

285

994

Other diseases of anus and rectum

1027

5839

1.82

65.84

1.9

1.29

1.40

g/l

0.63

915

5270

Marginal zone B-cell lymphoma

100

159

9.13

65.11

2.5

1.9

2.16

1.54

g/l

0.74

143

Vasculitis limited to skin, not elsewhere classified

174

438

4.67

64.84

2.1

1.6

1.26

1.45

g/l

0.46

157

399

Use of interferon beta-1a

172

430

4.72

64.73

3.5

1.7

0.95

1.36

g/l

3.69

167

403

Dental operations

2435

8527

1.49

64.62

1.9

1.8

1.27

1.32

g/l

0.48

2222

7737

STROKE

2056

9537

1.53

64.44

1.8

2.0

1.23

1.40

g/l

2.63

1877

8659

Arthrosis

2534

9614

1.48

64.35

1.8

1.9

1.29

1.36

g/l

0.75

2306

8755

Other diseases of blood and blood-forming organs

323

1192

2.95

63.87

2.1

1.8

1.47

1.36

g/l

0.26

294

1095

Gonarthrosis [arthrosis of knee](FG)

2470

10029

1.47

63.67

1.9

1.30

1.37

g/l

0.58

2213

9090

Other and unspecified vasculitis limited to skin

162

393

4.88

63.48

2.1

1.6

1.27

1.33

g/l

0.16

147

362

Other complications of surgical and medical care, not elsewhere classified

431

1833

2.51

63.08

2.3

1.8

1.33

1.35

g/l

0.03

404

1674

Obesity, other/unspecified

1257

7660

1.69

62.92

1.6

1.9

1.14

1.34

g/l

5.66

1159

7069

Paroxysmal tachycardia

786

3497

1.96

62.88

1.8

2.0

1.24

1.42

g/l

1.09

732

3208

Disorders of skin appendages

1776

11738

1.55

62.33

1.9

1.8

1.32

1.31

g/l

0.07

1627

10772

Other or unspecified immunodeficiency

17.87

61.94

4.6

2.0

1.19

1.55

g/l

0.40

Hypothyroidism, strict autoimmune, 3 medication purchases required

3091

15298

1.40

61.91

1.7

1.9

1.23

1.35

g/l

2.89

2783

13965

Disorders of conjunctiva

3025

18465

1.40

60.87

1.9

1.8

1.30

1.31

g/l

0.07

2782

16880

Mental and behavioural disorders due to alcohol

1833

11942

1.53

60.26

1.6

1.9

1.35

1.29

g/l

0.53

1646

10943

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

394

1646

2.57

60.10

2.5

1.8

1.39

g/l

0.02

365

1509

Sequelae with surgical and medical care as external cause

751

4010

1.96

60.08

2.0

1.9

1.22

1.38

g/l

1.32

687

3635

Other infectious diseases

351

1395

2.71

59.61

2.0

1.9

1.19

1.42

g/l

1.34

315

1271

Other symptoms and signs involving the circulatory and respiratory systems

290

1045

2.99

59.53

1.9

2.0

1.10

1.33

g/l

1.74

267

953

Ischemic heart diseases

2719

12149

1.43

59.50

1.8

1.9

1.27

1.37

g/l

1.22

2505

10996

Chronic laryngitis and laryngotracheitis

557

2691

2.18

59.36

1.7

1.8

1.31

1.38

g/l

0.31

488

2434

Injury, poisoning and certain other consequences of external causes

2260

7741

1.49

59.22

1.8

1.9

1.34

1.33

g/l

0.08

2083

7098

Ischaemic heart disease, wide definition

2677

11932

1.43

59.20

1.8

1.9

1.27

1.37

g/l

1.22

2459

10800

Other metabolic disorders

529

2511

2.22

59.05

2.0

1.9

1.30

1.38

g/l

0.28

491

2320

Diseases of middle ear and mastoid

2153

12177

1.48

59.00

1.9

1.8

1.26

1.30

g/l

0.45

1991

11193

Viral pneumonia (unknown virus, not influenza)

323

1243

2.82

58.82

3.3

1.8

1.42

1.35

g/l

0.20

301

1150

Use of teriflunomide

107

198

7.04

58.80

3.2

1.6

0.92

1.33

g/l

2.05

107

187

Benign neoplasm: Colon, unspecified

848

4729

1.87

58.79

1.7

1.8

1.29

1.35

g/l

0.24

760

4252

Benign neoplasm of other and ill-defined parts of digestive system

673

3496

2.02

58.62

1.8

1.9

1.39

1.38

g/l

0.03

626

3167

Symptoms and signs involving speech and voice

1176

7179

1.69

58.61

1.9

1.21

1.36

g/l

1.90

1079

6522

Acute suppurative otitis media

1060

5861

1.74

58.60

2.1

1.8

1.25

1.28

g/l

0.19

976

5465

Total colectomy operation

238

784

3.40

58.42

2.1

1.8

1.20

1.39

g/l

0.86

223

729

Total colectomy

238

784

3.40

58.42

2.1

1.8

1.20

1.39

g/l

0.86

223

729

Coeliac disease

526

2508

2.22

58.28

1.9

1.12

1.35

g/l

3.71

477

2305

Disorders of choroid and retina

2758

14477

1.41

58.22

1.9

1.38

1.33

g/l

0.42

2486

13143

Inflammatory diseases of the central nervous system

384

1618

2.55

57.62

2.2

1.8

1.26

1.35

g/l

0.29

353

1484

Diseases of spleen

132

296

5.42

57.55

2.3

1.5

1.09

1.56

g/l

1.15

117

275

Polyarthritis, unspecified

196

576

3.78

57.50

1.7

2.0

1.27

1.43

g/l

0.36

188

529

Other cataract

1455

7197

1.61

57.35

2.1

1.9

1.32

1.36

g/l

0.23

1327

6506

Pneumonia derived septicemia

200

601

3.76

57.11

2.6

1.8

1.28

1.41

g/l

0.25

180

549

Dizziness and giddiness

2625

15334

1.42

56.90

1.8

1.9

1.31

1.34

g/l

0.17

2383

13976

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1595

10509

1.55

56.66

1.5

1.9

1.35

1.29

g/l

0.56

1435

9630

Other abnormal findings of blood chemistry

223

718

3.45

56.64

2.5

1.7

1.68

1.47

g/l

0.32

215

655

Cellulitis

821

4588

1.86

56.59

1.9

1.8

1.27

1.30

g/l

0.17

740

4202

Cardiomyopathy

610

3094

2.05

56.43

2.0

1.9

1.25

1.39

g/l

0.60

567

2782

Unspecified haematuria

1387

7571

1.61

56.26

1.9

1.26

1.34

g/l

0.67

1238

6855

Other and unspecified diseases of blood and blood-forming organs

162

430

4.38

56.08

2.5

1.7

1.57

1.52

g/l

0.06

151

393

Suggestive for eosinophilic asthma

393

1692

2.48

56.03

1.9

1.24

1.42

g/l

0.84

368

1527

Dental caries 1

2913

10778

1.40

56.01

1.9

1.39

1.29

g/l

1.01

2670

9796

Dental caries, including avohilmo

2910

10768

1.40

55.98

1.9

1.39

1.30

g/l

1.00

2668

9786

Hyperparathyroidism

633

3227

2.02

55.77

1.8

1.21

1.38

g/l

1.50

569

2881

Thyroiditis, ILD-related definition

442

2012

2.31

54.76

1.9

1.7

1.28

1.42

g/l

0.92

401

1835

Endocarditis

184

537

3.82

54.62

1.8

1.14

1.44

g/l

1.09

174

486

Shoulder lesions

2718

12036

1.41

54.54

1.8

1.9

1.31

1.34

g/l

0.24

2486

10969

Iridocyclitis

856

4897

1.82

54.48

1.9

1.27

1.35

g/l

0.55

808

4487

Psoriatic arthropathies

419

1873

2.37

54.41

1.6

1.9

1.19

1.38

g/l

1.05

383

1712

Adjustment and management of implanted device

606

3107

2.03

54.37

1.8

1.9

1.36

1.48

g/l

0.34

556

2768

COPD, hospital admissions 3, with asthma pneumonia sepsis

874

4243

1.81

54.21

2.0

1.9

1.38

1.36

g/l

0.07

778

3784

Coxibs

1076

3369

1.74

54.15

1.8

1.9

1.28

1.37

g/l

0.69

970

3079

Other chronic obstructive pulmonary disease, including avohilmo

1737

9764

1.51

53.42

1.8

2.0

1.33

1.35

g/l

0.10

1570

8820

Drug-induced cataract

162

447

4.26

53.37

2.9

1.7

1.26

1.34

g/l

0.21

151

408

Other viral diseases, not elsewhere classified

752

4164

1.88

53.09

2.3

1.8

1.25

1.29

g/l

0.27

701

3860

Other retinal disorders

2071

11630

1.46

53.02

1.9

1.37

1.32

g/l

0.28

1855

10504

Other specified/unspecified necrotizing vasculopathies

111

231

5.92

53.01

2.1

1.7

0.89

1.46

g/l

2.27

105

212

Substance use, excluding alcohol

768

4291

1.86

52.99

1.6

1.9

1.34

1.29

g/l

0.38

706

3955

Dermatitis due to substances taken internally

266

978

2.95

52.98

2.3

1.8

1.17

1.34

g/l

0.57

243

896

Osteonecrosis

271

1008

2.94

52.98

2.7

1.8

0.97

1.44

g/l

3.65

250

919

Paralytic ileus and intestinal obstruction

837

4786

1.80

52.84

1.9

1.29

1.41

g/l

0.58

766

4298

Nephrotic syndrome

196

614

3.64

52.73

2.3

1.7

1.28

1.35

g/l

0.11

183

570

Vascular disorders of the intestines

260

942

2.95

52.73

1.8

1.7

1.23

1.43

g/l

0.83

240

837

Voice disturbances

959

5713

1.74

52.72

1.9

1.19

1.35

g/l

2.22

887

5202

Stomatitis and related lesions

357

1512

2.51

52.66

2.1

1.8

1.15

1.39

g/l

2.15

327

1375

Non-selective monoamine reuptake inhibitors

1357

8513

1.59

52.54

1.7

1.9

1.23

1.34

g/l

1.35

1225

7761

Myeloproliferative diseases

352

1488

2.54

52.44

1.9

1.51

1.44

g/l

0.17

319

1341

Temporal arteritis

185

558

3.72

52.41

1.6

1.8

1.21

1.49

g/l

0.72

168

499

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

887

5190

1.77

52.16

1.5

2.0

1.11

1.38

g/l

6.06

809

4751

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

988

5935

1.71

52.08

1.8

1.35

1.32

g/l

0.25

895

5518

Dental caries 3

3084

11655

1.37

52.08

1.9

1.40

1.30

g/l

1.09

2835

10609

Injuries to the head

4011

20199

1.31

51.85

1.8

1.9

1.29

1.31

g/l

0.22

3648

18479

Migraine with aura

880

5137

1.77

51.80

1.7

1.8

1.25

1.34

g/l

1.51

823

4751

Conjunctivitis

2716

17426

1.38

51.78

2.0

1.8

1.32

1.30

g/l

0.16

2494

15961

Hypertensive heart and/or renal disease

792

3430

1.84

51.73

1.7

2.2

1.22

1.56

g/l

3.39

711

3074

Kidney transplant status

274

1042

2.90

51.67

2.2

1.9

1.11

1.31

g/l

1.25

257

970

Diseases of the myoneural junction and muscle

472

2262

2.20

51.65

1.8

1.9

1.11

1.39

g/l

3.18

426

2043

Dental pulpitis 2

2588

9542

1.41

51.39

1.9

1.8

1.32

1.29

g/l

0.22

2371

8675

Lumbar disc prolapse

2199

12412

1.43

51.34

1.8

1.9

1.33

1.34

g/l

0.08

2019

11361

Hernia

3378

17359

1.34

51.11

1.9

1.36

1.30

g/l

0.64

3077

15846

Invasive ventilation

324

1337

2.61

51.05

2.0

1.8

1.21

1.39

g/l

0.94

290

1231

Psoriasis vulgaris

719

3989

1.88

50.96

1.7

1.9

1.35

g/l

0.02

655

3672

COPD, hospital admissions

1443

8028

1.56

50.88

1.8

1.9

1.37

g/l

0.02

1301

7208

Nonsuppurative otitis media

914

4657

1.75

50.82

2.0

1.8

1.18

1.31

g/l

1.74

854

4297

Secondary right heart disease

203

659

3.40

50.82

2.3

1.7

1.18

1.59

g/l

1.36

194

597

Suppurative and unspecified otitis media

1367

7894

1.57

50.62

2.0

1.8

1.28

g/l

0.03

1265

7307

Intestinal malabsorption

234

829

3.11

50.31

1.9

1.8

1.10

1.44

g/l

2.07

208

764

Paracetamol of NSAID medication

738

1982

1.92

50.30

1.8

1.42

1.27

g/l

0.56

682

1828

137

348

4.51

50.12

2.1

1.9

1.05

1.58

g/l

2.03

127

311

COPD, early/later onset

1447

8078

1.55

49.61

1.8

1.9

1.37

g/l

0.02

1306

7254

Spinal stenosis

1632

8646

1.51

49.56

1.9

1.31

1.39

g/l

0.50

1461

7815

Pacemaker

986

5830

1.69

49.41

1.8

1.9

1.30

1.41

g/l

0.45

888

5176

Cholecystitis

481

2354

2.13

49.29

1.8

1.9

1.27

1.41

g/l

1.01

424

2115

Other pulmonary heart/vessel disease

217

747

3.18

49.00

2.2

1.7

1.20

1.60

g/l

1.44

208

679

Other arthrosis

1697

8261

1.50

48.99

1.8

1.9

1.29

1.36

g/l

0.54

1540

7508

Conduction disorders

916

4522

1.73

48.97

1.9

1.32

1.39

g/l

0.33

826

4043

COPD-related respiratory insufficiency

420

1965

2.25

48.73

2.1

1.9

1.18

1.39

g/l

1.56

379

1752

Alcohol use disorder, ICD-based

1459

9765

1.53

48.48

1.5

1.9

1.36

1.29

g/l

0.64

1312

8953

Coxarthrosis [arthrosis of hip](FG)

1623

7935

1.51

48.43

1.8

2.0

1.17

1.41

g/l

4.33

1468

7128

Other and unspecified urticaria

760

4351

1.82

48.40

1.9

1.8

1.30

1.32

g/l

0.09

692

4027

Golimumab

194

634

3.43

48.39

1.7

1.8

1.29

1.30

g/l

0.02

184

592

Other and unspecified drugs and medicaments

354

1559

2.43

48.06

2.6

1.8

1.37

1.41

g/l

0.09

329

1419

Benign neoplasm: Caecum

353

1549

2.41

48.00

1.7

1.4

1.56

1.17

g/l

1.54

323

1394

Pain and other conditions associated with female genital organs and menstrual cycle

748

4087

1.81

47.74

1.7

1.8

1.26

1.34

g/l

1.05

672

3749

Giant cell arteritis with polymyalgia rheumatica

185

592

3.49

47.73

1.6

1.8

1.21

1.61

g/l

1.06

168

531

Other and unspecified effects of external causes

1025

6370

1.66

47.69

1.9

1.8

1.44

1.31

g/l

1.01

945

5884

Personality disorders, excluding more controls

913

5503

1.71

47.65

1.7

1.8

1.28

1.31

g/l

0.15

819

5130

Excessive, frequent and irregular menstruation

1464

5358

1.55

47.61

1.7

1.8

1.32

1.35

g/l

0.26

1333

4875

Hard cardiovascular diseases

2670

12668

1.38

47.42

1.8

2.0

1.20

1.38

g/l

4.62

2433

11499

Other and unspecified tonsillitis

1201

6531

1.60

47.34

1.9

1.8

1.28

1.27

g/l

0.05

1113

6068

Subjective visual disturbances

871

5207

1.73

47.31

1.9

1.8

1.21

1.34

g/l

1.19

784

4749

Later onset COPD, excluding more controls

542

2148

2.03

47.28

1.6

1.8

1.53

1.48

g/l

0.11

484

1877

Hypermobility syndrome

248

932

2.87

47.28

2.1

1.8

1.27

1.36

g/l

0.68

232

866

Migraine without aura

745

4263

1.81

47.22

1.9

1.8

1.22

1.32

g/l

1.81

687

3956

Other and unspecified aplastic anaemias

192

6.20

47.14

2.3

1.5

1.46

1.22

g/l

0.37

178

Pruritus

420

1992

2.22

47.13

2.0

1.8

1.57

1.37

g/l

0.50

381

1814

Need for other prophylactic measures

266

1041

2.78

47.12

2.2

1.8

1.16

1.35

g/l

0.86

249

964

Polycystic ovarian syndrome, consortium definition

2509

11072

1.39

47.08

1.8

1.34

1.35

g/l

0.07

2292

10107

COPD related to multimorbidity

1209

6557

1.59

46.77

1.7

1.9

1.29

1.38

g/l

0.49

1089

5858

Enteropathic arthropathies

139

375

4.21

46.69

1.7

1.37

1.47

g/l

0.22

128

347

Rash and other nonspecific skin eruption

406

1912

2.25

46.63

2.0

1.8

1.18

1.33

g/l

1.01

389

1748

Reactive arthropathies, FINNGEN

296

1219

2.58

46.50

1.9

1.25

1.33

g/l

0.41

279

1116

Other peripheral vascular diseases

335

1462

2.44

46.36

1.8

1.31

1.42

g/l

0.62

306

1329

Disorders of synovium and tendon

1821

11520

1.45

46.19

1.7

1.9

1.24

1.35

g/l

1.36

1656

10540

AV-block

524

2438

2.02

46.12

1.8

1.9

1.32

1.46

g/l

0.45

468

2163

Other abnormal immunological findings in serum

124

313

4.58

45.93

2.1

1.7

1.37

1.33

g/l

0.08

114

287

Other specified/unspecified inflammatory spondylopathies

238

890

2.89

45.91

1.7

1.9

1.33

1.49

g/l

0.56

225

828

Irregular menses

1677

9416

1.48

45.58

1.8

1.33

1.34

g/l

0.10

1551

8654

Pericarditis

179

575

3.42

45.55

2.6

1.8

1.16

1.54

g/l

1.42

171

527

Disorders of oesophagus in diseases classified elsewhere

125

320

4.53

45.47

2.5

1.7

1.25

1.46

g/l

0.53

112

290

Injuries to the thorax

1470

9984

1.51

45.34

1.9

1.30

1.33

g/l

0.26

1343

9055

Calcific aortic valvular stenosis, including rheumatic fever

865

5093

1.71

45.19

1.8

1.9

1.40

1.42

g/l

0.09

763

4515

Calcific aortic valvular stenosis, operated

864

5091

1.71

45.17

1.8

1.9

1.36

1.43

g/l

0.27

762

4513

Calcific aortic valvular stenosis

864

5091

1.71

45.17

1.8

1.9

1.36

1.43

g/l

0.27

762

4513

Pneumococcal septicemia

183

602

3.40

45.16

2.7

1.7

1.32

1.41

g/l

0.16

166

554

Calcific aortic valvular stenosis, diagnosis (helper)

861

5075

1.71

44.95

1.8

1.9

1.36

1.43

g/l

0.27

759

4497

Operations 2 for CAVS

861

5075

1.71

44.95

1.8

1.9

1.36

1.43

g/l

0.27

759

4497

Preparatory care for dialysis

213

765

3.08

44.89

1.7

1.8

1.08

1.46

g/l

1.83

201

708

Gonarthrosis

2118

8693

1.42

44.73

1.8

1.9

1.30

1.37

g/l

0.60

1902

7901

Presence of cardiac and vascular implants and grafts

1352

6790

1.54

44.72

1.6

1.9

1.23

1.39

g/l

1.22

1225

6098

Other juvenile arthritis

209

743

3.06

44.40

2.0

1.9

1.28

1.32

g/l

0.21

191

692

Other diseases of stomach and duodenum

259

1025

2.70

44.40

1.7

1.8

1.22

1.44

g/l

1.31

243

925

Injuries to the abdomen, lower back, lumbar spine and pelvis

1294

8547

1.54

44.29

1.9

1.8

1.35

1.34

g/l

0.03

1163

7743

Dental pulpitis 2, only avohilmo

2610

9872

1.37

44.28

1.8

1.9

1.34

1.29

g/l

0.43

2387

8977

Acute generalized exanthematous pustulosis

222

821

2.96

44.08

2.4

1.8

1.18

1.50

g/l

1.04

206

759

Parodontitis or operation codes

3116

17600

1.32

43.94

1.9

1.33

1.31

g/l

0.10

2823

16075

Elevated blood glucose level

329

1458

2.40

43.90

2.1

1.8

1.18

1.37

g/l

1.39

304

1323

Disorders of tooth development and eruption

251

957

2.74

43.83

2.7

1.7

1.11

1.26

g/l

1.14

238

896

Dental pulpitis 4, only avohilmo

4111

16929

1.28

43.75

1.8

1.9

1.32

1.30

g/l

0.15

3771

15449

Juvenile arthritis (FINNGEN)

230

868

2.86

43.55

2.0

1.9

1.25

1.29

g/l

0.17

211

808

Myocarditis

199

692

3.07

43.53

2.3

2.0

1.33

1.54

g/l

0.39

182

638

Ankylosing spondylitis

378

1780

2.24

43.35

1.5

1.9

1.26

1.42

g/l

1.10

357

1642

Parodontitis

3108

17599

1.32

43.29

1.9

1.33

1.31

g/l

0.12

2816

16074

Inflammatory diseases of female pelvic organs

2098

11465

1.40

43.28

1.8

1.37

1.34

g/l

0.28

1902

10488

Mantle cell lymphoma

136

7.23

43.24

2.3

1.8

0.88

1.65

g/l

0.92

121

Hypoparathyroidism

182

612

3.30

43.15

2.7

1.7

1.14

1.38

g/l

1.30

163

550

Emphysema

266

1079

2.62

43.15

2.0

1.19

1.37

g/l

1.00

243

964

Pyogenic arthritis

266

1079

2.62

43.14

1.8

2.0

1.17

1.49

g/l

1.84

241

976

Fracture of lumbar spine and pelvis

685

3928

1.80

42.95

2.0

1.8

1.38

g/l

0.01

610

3516

Abnormal findings on examination of urine, without diagnosis

217

805

2.95

42.85

2.7

1.8

1.16

1.48

g/l

1.58

205

738

Adverse effects, not elsewhere classified

742

4371

1.76

42.74

2.0

1.8

1.44

1.33

g/l

0.56

683

4036

Generalized skin eruption due to drugs and medicaments

203

730

3.07

42.63

2.5

1.9

1.17

1.53

g/l

1.07

187

674

Statin medication

2646

11094

1.36

42.53

1.6

2.0

1.13

1.39

g/l

13.05

2442

10186

Disorders resulting from impaired renal tubular function

190

663

3.20

42.41

1.8

1.7

1.05

1.47

g/l

2.36

172

618

Other disorders of kidney and ureter

467

2396

2.05

42.41

2.0

1.9

1.37

1.38

g/l

0.01

426

2168

Chronic periodontitis, including avohilmo

3089

17603

1.32

42.24

1.9

1.34

1.31

g/l

0.26

2799

16079

Viral pneumonia (known virus, not influenza)

144

429

3.86

42.14

3.5

1.7

1.36

1.48

g/l

0.14

132

399

Reactive arthropathies

350

1616

2.28

42.09

1.9

1.27

1.39

g/l

0.63

330

1478

Soft tissue disorders related to use, overuse and pressure

900

5586

1.66

42.03

1.8

2.0

1.41

1.38

g/l

0.14

816

5079

Nonorganic sleeping disorders, excluding more controls

642

3643

1.82

41.98

1.8

1.31

1.33

g/l

0.10

588

3372

Special screening examination for infectious and parasitic diseases

839

3769

1.70

41.96

1.8

1.7

1.30

1.29

g/l

0.05

751

3500

Coronary atherosclerosis

2204

10399

1.39

41.92

1.8

2.0

1.23

1.37

g/l

1.69

2022

9381

Allergic rhinitis

1168

7624

1.56

41.92

1.8

1.21

1.29

g/l

1.23

1064

7088

Recurring oral aphthae, including avohilmo

522

2791

1.96

41.90

2.0

1.9

1.13

1.37

g/l

3.94

493

2558

Pneumonia due to Streptococcus pneumoniae

188

652

3.12

41.70

2.2

1.7

1.06

1.34

g/l

1.62

166

602

Deforming dorsopathies

965

6101

1.63

41.69

2.0

1.9

1.30

1.36

g/l

0.26

877

5554

Atopic dermatitis, strict definition with reimbursement

1105

6978

1.57

41.65

1.8

1.20

1.26

g/l

0.82

1035

6477

Keratitis

1210

8052

1.54

41.52

1.9

1.8

1.28

1.33

g/l

0.40

1109

7360

Recurring oral aphthae

223

853

2.85

41.46

2.4

1.8

1.08

1.39

g/l

1.87

207

784

Hypertensive Heart Disease

675

3159

1.80

41.18

1.6

2.2

1.24

1.56

g/l

2.88

601

2825

Other skin changes

589

3286

1.87

41.09

2.2

1.8

1.34

1.38

g/l

0.16

546

2966

Type 1 diabetes

916

5733

1.64

41.06

1.7

1.9

1.21

1.34

g/l

1.67

838

5268

Unknown and unspecified causes of morbidity

267

1109

2.53

40.92

2.2

1.8

1.16

1.40

g/l

1.57

254

992

Other disorders of bone

734

4364

1.74

40.79

2.1

1.8

1.19

1.34

g/l

1.49

656

4025

Isolated proteinuria

162

528

3.44

40.73

2.9

1.7

1.07

1.46

g/l

2.12

153

491

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

195

701

3.02

40.61

1.6

1.8

1.47

1.60

g/l

0.27

168

634

Other or unspecified ileus, impaction or obstruction

573

3172

1.87

40.55

1.9

1.8

1.35

1.39

g/l

0.12

523

2834

Malignant neoplasm of liver and intrahepatic bile ducts

154

486

3.50

40.49

1.6

1.8

1.60

1.65

g/l

0.08

132

441

Anterior Iridocyclitis

741

4430

1.73

40.40

1.9

1.8

1.30

1.33

g/l

0.17

703

4067

Myositis

144

439

3.68

40.27

1.7

1.06

1.47

g/l

1.48

135

399

Dental pulpitis 1, only avohilmo

4091

17013

1.27

40.20

1.8

1.9

1.32

1.30

g/l

0.16

3750

15527

Other coagulation defects

301

1336

2.40

40.17

2.1

1.8

1.30

1.45

g/l

0.49

284

1232

Other CVD

586

3285

1.85

39.93

2.1

1.8

1.33

1.39

g/l

0.20

526

2927

Acute pharyngitis

540

2933

1.89

39.90

1.8

1.12

1.30

g/l

3.33

502

2748

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

375

1822

2.18

39.81

2.2

1.8

1.19

1.38

g/l

0.88

353

1650

Exposure to other specified factors

2580

18420

1.33

39.72

1.8

1.9

1.25

1.30

g/l

0.57

2352

16896

Diabetic nephropathy, excluding more controls

546

2493

1.92

39.69

1.7

1.10

1.27

g/l

1.54

502

2229

Idiopathic gout

323

1483

2.30

39.58

1.6

1.8

1.25

1.42

g/l

0.35

306

1335

Somatoform disorder

606

3449

1.82

39.48

1.8

1.25

1.36

g/l

0.79

546

3182

Intestinal stricture

979

6292

1.60

39.48

1.9

1.35

g/l

0.02

899

5668

Arthropathic psoriasis

442

2283

2.03

39.47

1.6

1.9

1.14

1.35

g/l

2.63

402

2105

Coxarthrosis

1529

7202

1.47

39.45

1.8

2.0

1.15

1.39

g/l

4.37

1382

6501

Acetic acid derivatives and related substances

1014

3323

1.62

39.35

1.7

1.9

1.23

1.38

g/l

1.47

925

3034

Parodontitis and operation codes

2910

17471

1.31

39.33

1.9

1.33

1.31

g/l

0.17

2637

15951

Acute and subacute iridocyclitis

696

4123

1.75

39.28

1.9

1.8

1.31

1.35

g/l

0.19

660

3790

Retention of urine

1026

5605

1.58

39.20

2.0

1.9

1.41

1.38

g/l

0.12

918

5055

Ulcerative proctitis

267

1138

2.51

39.17

1.9

1.8

1.23

1.39

g/l

0.80

249

1051

Benign neoplasm: Transverse colon

329

1526

2.27

39.16

2.0

1.4

1.24

1.13

g/l

0.58

302

1375

Heart failure and coronary heart disease

955

4510

1.62

39.03

1.7

1.9

1.09

1.50

g/l

7.57

864

3981

Injuries to the ankle and foot

2438

16814

1.34

38.95

1.8

1.31

1.29

g/l

0.19

2222

15465

Cardiomyopathy in other diseases

9.85

38.89

4.1

1.6

1.72

1.91

g/l

0.07

Atopic dermatitis

1939

12093

1.39

38.74

1.7

1.8

1.26

1.28

g/l

0.16

1803

11156

Other and unspecified acquired haemolytic anaemias

166

6.10

38.72

2.6

1.8

2.06

1.62

g/l

0.39

150

Complications of internal orthopaedic prosthetic devices, implants and grafts

699

4157

1.74

38.70

1.7

1.9

1.10

1.41

g/l

5.45

619

3718

Lung diseases due to external agents

453

2367

1.99

38.67

1.8

1.9

1.27

1.41

g/l

0.66

401

2121

Injuries to the knee and lower leg

4266

19671

1.26

38.58

1.8

1.9

1.24

1.32

g/l

2.10

3903

17970

Internal derangement of knee

1219

8214

1.51

38.57

1.9

1.33

g/l

0.00

1094

7485

Benign neoplasm: Rectum, anus and anal canal

583

3301

1.83

38.43

2.0

1.5

1.56

1.21

g/l

1.67

534

2977

Congenital malformations, deformations and chromosomal abnormalities

2097

14925

1.37

38.39

1.9

1.8

1.29

g/l

0.00

1967

13704

Duodenal ulcer

354

1698

2.17

38.36

1.5

1.9

1.17

1.42

g/l

1.75

324

1507

Special screening examination for other diseases and disorders

308

1399

2.30

38.31

1.7

1.9

1.22

1.33

g/l

0.31

282

1283

Other encephalitis

152

496

3.43

38.14

2.4

1.7

1.12

1.43

g/l

1.10

136

460

Fracture of rib(s), sternum and thoracic spine

946

6082

1.60

38.12

1.9

1.8

1.25

1.32

g/l

0.46

868

5499

Peripheral artery disease

1293

7101

1.50

37.84

1.7

1.9

1.25

1.43

g/l

1.65

1172

6338

Dermatographic urticaria

287

1282

2.39

37.80

2.2

1.8

1.32

1.41

g/l

0.31

267

1186

Neuromuscular dysfunction of bladder

343

1642

2.20

37.77

2.1

1.9

1.19

1.44

g/l

1.57

319

1499

Hypersplenism

11.02

37.76

3.1

1.9

1.18

1.79

g/l

0.56

Ovarian cyst

1309

5123

1.51

37.72

1.8

1.29

1.35

g/l

0.80

1209

4659

Diplopia

472

2530

1.95

37.59

2.0

1.9

1.27

1.38

g/l

0.42

441

2297

Benign neoplasm: Rectum

521

2876

1.88

37.47

2.0

1.5

1.43

1.19

g/l

1.36

477

2594

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1017

6595

1.57

37.44

1.9

1.8

1.20

1.32

g/l

2.36

946

6126

Polyuria

715

4320

1.71

37.32

2.1

1.9

1.31

1.38

g/l

0.30

632

3895

Cervical disc disorders

1194

8110

1.50

36.98

1.9

1.28

1.36

g/l

0.54

1071

7394

Other neurological diseases

2318

14087

1.34

36.87

2.0

1.9

1.28

1.35

g/l

0.51

2112

12760

Behavioural syndromes associated with physiological disturbances and physical factors

1123

7541

1.52

36.83

1.8

1.28

1.30

g/l

0.22

1023

6984

Fissure and fistula of anal and rectal regions

811

5078

1.64

36.57

1.9

1.8

1.14

1.37

g/l

2.88

735

4632

Conjunctivitis (acute, non atopic)

983

6417

1.57

36.51

2.2

1.8

1.29

g/l

0.02

913

5896

Benign neoplasm: Ascending colon

395

2012

2.05

36.48

2.0

1.4

1.45

1.15

g/l

1.40

366

1808

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

184

5.29

36.44

1.7

1.2

1.00

1.13

g/l

0.33

169

Dental caries 1, only avohilmo

2878

11355

1.31

36.42

1.9

1.40

1.29

g/l

1.25

2638

10337

Encephalitis

157

536

3.26

36.41

2.4

1.7

1.13

1.43

g/l

1.18

141

496

Suppurative and necrotic conditions of lower respiratory tract

231

956

2.60

36.35

2.3

1.8

1.34

1.41

g/l

0.13

208

874

Problems related to lifestyle

391

1988

2.05

36.35

1.6

1.8

1.44

1.36

g/l

0.26

345

1822

Other acute viral hepatitis

228

4.89

36.31

1.6

1.5

1.58

1.41

g/l

0.34

209

Migraine with aura and triptan purchases

554

3158

1.82

35.90

1.7

1.8

1.24

1.33

g/l

1.22

522

2927

Atypical mycobacterium lung infection

196

5.22

35.88

1.8

1.9

1.34

1.41

g/l

0.10

174

Spondylopathies in diseases classified elsewhere

175

5.44

35.84

4.5

1.8

0.59

1.83

g/l

2.46

158

Secondary thrombocytopenia

209

5.07

35.83

2.7

1.5

1.17

1.38

g/l

0.47

191

Dental caries 3, only avohilmo

3050

12166

1.30

35.52

1.8

1.9

1.40

1.29

g/l

1.25

2801

11086

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

139

6.17

35.29

1.3

1.4

1.14

1.13

g/l

0.02

129

Benign neoplasm: Sigmoid colon

524

2951

1.84

35.26

1.9

1.5

1.35

1.21

g/l

0.63

485

2646

Disorder of lipoprotein metabolism, unspecified

425

2254

1.96

34.76

1.7

1.8

1.10

1.49

g/l

5.42

385

2016

Pollen allergy

727

4448

1.67

34.75

1.8

1.26

g/l

0.01

659

4150

CR(E)ST syndrome

105

290

4.26

34.75

1.7

1.65

1.36

g/l

0.84

264

Erosion of teeth

104

284

4.21

34.67

2.2

1.5

1.05

1.16

g/l

0.46

266

Hypotension

483

2672

1.87

34.48

2.2

1.8

1.34

1.42

g/l

0.21

431

2373

Ankylosing spondylitis, ICD10

367

1866

2.07

34.46

1.5

1.9

1.26

1.35

g/l

0.55

347

1734

Other psoriatic arthropathies

401

2103

2.00

34.36

1.6

1.9

1.21

1.32

g/l

0.59

366

1932

Postprocedural disorders of nervous system

303

1437

2.23

34.33

2.1

1.8

1.18

1.39

g/l

1.67

288

1331

Simple and mucopurulent chronic bronchitis

178

665

2.86

34.33

1.8

1.9

1.27

1.45

g/l

0.63

168

602

Disorders of muscles

375

1920

2.04

34.26

1.6

1.9

1.04

1.38

g/l

5.57

350

1754

Biological medicines for asthma

244

4.55

33.93

1.5

1.6

1.04

1.45

g/l

1.62

225

Vitamin deficiency

201

805

2.68

33.84

2.2

1.8

1.35

1.47

g/l

0.30

181

737

Vitamin deficiency, wide

201

805

2.68

33.84

2.2

1.8

1.35

1.47

g/l

0.30

181

737

Donors of organs and tissues

244

4.51

33.81

3.3

1.6

0.97

1.32

g/l

0.71

226

Osteomyelitis

249

1100

2.41

33.69

2.1

1.8

1.37

1.43

g/l

0.12

222

1013

Pain in thoracic spine

527

3017

1.81

33.63

1.9

1.29

1.36

g/l

0.25

497

2771

Other embolism and thrombosis

443

2411

1.91

33.57

2.1

1.9

1.13

1.39

g/l

2.84

409

2183

Psoriatic arthropathies, ICD10

410

2186

1.97

33.43

1.6

1.9

1.19

1.32

g/l

0.65

374

2012

Chronic diseases of tonsils and adenoids

2776

13725

1.30

33.29

1.8

1.9

1.26

1.32

g/l

0.86

2573

12597

Postprocedural endocrine and metabolic disorders, not elsewhere classified

424

2283

1.93

33.24

1.9

1.24

1.39

g/l

0.79

396

2101

Atherosclerosis, excluding cerebral and coronary sclerosis

1176

6460

1.48

33.17

1.7

1.9

1.25

1.42

g/l

1.58

1065

5739

Abnormality of white blood cells, not elsewhere classified

136

6.15

33.15

2.0

1.6

1.29

1.38

g/l

0.13

124

Intracranial injury

1876

13548

1.36

33.06

1.8

1.9

1.31

1.32

g/l

0.04

1686

12373

Colectomy operation

554

3236

1.77

33.05

2.1

1.9

1.46

1.35

g/l

0.28

507

2924

Chronic nephritic syndrome

185

724

2.78

32.93

2.4

1.8

1.32

1.44

g/l

0.22

173

672

Benign neoplasm: Stomach

317

1551

2.14

32.90

1.8

1.4

1.51

1.19

g/l

0.97

289

1411

Dialysis

188

743

2.75

32.85

2.2

1.8

1.07

1.40

g/l

1.65

175

693

Other disorders of ear

3122

16535

1.27

32.74

2.0

1.9

1.31

g/l

0.06

2810

15101

Hernia of abdominal wall

1436

10332

1.42

32.57

1.8

1.9

1.37

1.32

g/l

0.27

1313

9402

Hyperkinetic disorders, excluding more controls

368

1847

2.01

32.57

1.5

1.8

1.26

1.21

g/l

0.58

338

1729

Other and unspecified coagulation defects

216

913

2.55

32.56

2.2

1.8

1.42

1.50

g/l

0.16

205

845

Transport accidents

1556

10027

1.40

32.43

1.7

1.9

1.27

1.32

g/l

0.38

1432

9236

Other diseases of oesophagus

314

1537

2.13

32.41

1.9

1.69

1.39

g/l

0.52

285

1383

L01XX Other antineoplastic agents

221

945

2.51

32.39

2.2

1.9

1.16

1.59

g/l

2.04

190

846

Other problems related to primary support group, including family circumstances

462

2512

1.87

32.35

2.1

1.8

1.12

1.27

g/l

2.41

430

2347

Other disorders of eye and adnexa

503

2889

1.81

31.97

2.0

1.8

1.18

1.34

g/l

1.84

466

2658

Cardiodefibrillation

1082

7415

1.49

31.96

2.0

1.9

1.20

1.39

g/l

1.91

998

6652

Liver disorders in diseases classified elsewhere

11.95

31.83

1.6

1.7

2.13

1.02

g/l

3.40

UC patients in KELA-register (code 208), prior to 1994

200

826

2.61

31.77

2.2

1.7

1.26

1.38

g/l

0.40

190

762

Benign neoplasm: Caecum

353

1827

2.03

31.50

1.7

1.9

1.56

1.39

g/l

0.44

323

1650

Viral and other specified intestinal infections

735

4549

1.62

31.42

2.1

1.7

1.22

1.26

g/l

0.34

683

4201

Aspergillosis

143

5.89

31.42

2.7

1.6

1.28

1.37

g/l

0.10

130

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1112

7704

1.48

31.38

1.9

1.30

1.33

g/l

0.16

1032

7052

Myeloproliferative diseases (CML excluded)

282

1350

2.21

31.27

2.0

1.8

1.61

1.41

g/l

0.52

254

1227

In situ neoplasms

1000

6460

1.51

31.24

2.1

1.5

1.18

1.27

g/l

1.05

897

5845

COPD, hospital admissions 1, only main diagnosis

1012

5837

1.51

31.20

1.9

1.43

1.35

g/l

0.29

896

5218

Rotator cuff syndrome

1968

11041

1.34

31.16

1.7

1.9

1.25

1.35

g/l

0.94

1816

10059

Menorrhagia

1219

4668

1.47

31.12

1.7

1.9

1.34

1.35

g/l

0.06

1114

4230

Excessive attrition of teeth

1357

5201

1.44

31.07

1.8

1.33

g/l

0.04

1252

4784

Contact with and exposure to communicable diseases

1118

7740

1.47

30.89

2.3

1.8

1.28

1.27

g/l

0.05

1055

7196

Misadventures to patients during surgical and medical care

473

2695

1.82

30.86

2.0

1.9

1.36

1.37

g/l

0.05

430

2454

Temporomandibular joint disorders, including avohilmo

1416

10244

1.41

30.84

1.9

1.8

1.23

1.33

g/l

1.67

1303

9423

Cerebrovascular diseases

2312

12805

1.31

30.83

1.7

2.0

1.19

1.36

g/l

3.81

2081

11601

Haemorrhoids and perianal venous thrombosis

862

5683

1.55

30.82

1.9

1.44

1.43

g/l

0.02

775

5094

Persons encountering health services for specific procedures, not carried out

292

1425

2.16

30.67

1.8

1.44

1.40

g/l

0.13

270

1310

Rosacea

414

2276

1.90

30.60

2.1

1.8

1.36

1.38

g/l

0.04

382

2086

Localized swelling, mass and lump of skin and subcutaneous tissue

1011

6909

1.50

30.60

2.0

1.8

1.32

1.31

g/l

0.05

948

6287

Microscopic polyangiitis

106

7.09

30.41

2.1

1.8

0.81

1.54

g/l

1.48

Dental operations, only avohilmo

2436

9653

1.31

30.34

1.9

1.32

1.31

g/l

0.02

2214

8780

Ocular pain

308

1541

2.10

30.30

2.1

1.9

1.19

1.43

g/l

1.64

288

1415

Carrier of infectious disease

126

422

3.32

30.28

2.0

1.7

1.32

1.54

g/l

0.50

117

386

Phlebitis and thrombophlebitis (not including DVT)

717

4569

1.61

30.23

2.2

1.9

1.19

1.36

g/l

1.76

654

4158

Chronic myeloid leukaemia [CML], BCR/ABL-positive

161

5.30

29.82

1.3

1.9

1.14

1.42

g/l

0.43

146

Arthropathies in other diseases classified elsewhere

150

554

2.92

29.78

1.8

1.9

1.36

1.46

g/l

0.16

133

511

Amputation

314

1587

2.06

29.72

1.7

2.0

1.23

1.47

g/l

0.99

275

1424

Small fibre neuropathy

138

493

3.11

29.67

3.2

1.6

1.84

1.45

g/l

0.70

125

450

Oxicams

795

2890

1.60

29.66

1.9

1.22

1.40

g/l

1.14

709

2637

Melanocytic naevi

880

5884

1.53

29.63

2.1

1.6

1.41

1.25

g/l

1.00

817

5406

Poisoning by drugs, medicaments and biological substances

835

5529

1.55

29.61

1.7

1.8

1.36

1.32

g/l

0.25

754

5126

Meniscus derangement

1741

8890

1.36

29.53

2.0

1.9

1.32

1.36

g/l

0.20

1595

8092

Exclusions for E4_PCOS_CONSORTIUM

2517

12367

1.29

29.48

1.7

1.8

1.27

1.33

g/l

1.02

2315

11341

Renal tubulo-interstitial disorders in diseases classified elsewhere

175

5.04

29.47

3.9

1.6

0.85

1.83

g/l

1.60

160

Other and unspecified rosacea

317

1620

2.06

29.40

1.8

1.22

1.43

g/l

0.73

289

1489

Disorders of ocular muscles, binocular movement, accommodation and refraction

1583

11662

1.37

29.38

2.0

1.8

1.32

1.30

g/l

0.11

1462

10713

Osteonecrosis due to drugs

220

4.49

29.27

3.7

1.7

0.73

1.70

g/l

2.29

198

Hepatocellular carcinoma

102

307

3.72

29.23

1.5

1.7

1.80

1.54

g/l

0.34

280

Open wound of head

1661

12243

1.36

29.23

1.8

1.9

1.32

1.31

g/l

0.06

1496

11142

Phobic anxiety disorders

476

2757

1.78

29.19

1.9

1.8

1.30

1.31

g/l

0.05

440

2573

Migraine without aura and triptan purchases

566

3445

1.69

28.91

1.8

1.22

1.31

g/l

1.42

524

3204

Cerebral cysts

225

1018

2.35

28.83

1.9

1.8

1.26

1.42

g/l

0.74

210

935

Type 1 diabetes, wide definition, subgroup 1

722

4660

1.59

28.62

1.7

1.9

1.23

1.36

g/l

1.41

656

4283

Viral infections of the central nervous system

279

1377

2.13

28.52

2.2

1.8

1.20

1.35

g/l

0.83

253

1272

Unspecified fall

1555

11505

1.36

28.12

1.9

1.36

1.31

g/l

0.29

1400

10489

Post-traumatic stress disorder

297

1503

2.06

28.10

1.7

1.8

1.48

1.35

g/l

0.39

269

1401

Cardiomyopathies, Primary/intrinsic

382

2099

1.88

28.05

1.6

1.9

1.16

1.37

g/l

1.06

357

1882

Haemorrhage, not elsewhere classified

130

458

3.03

28.03

1.6

1.7

1.13

1.39

g/l

0.94

120

413

Diabetic nephropathy

549

3311

1.70

27.98

1.7

1.10

1.22

g/l

1.04

505

2982

Panic disorder

513

3071

1.72

27.90

1.7

1.8

1.25

1.32

g/l

0.69

471

2866

Mature T/NK-cell lymphomas, hilmo

227

4.24

27.79

1.7

1.6

1.00

1.41

g/l

1.04

205

Cervicalgia

655

4173

1.61

27.63

1.7

1.9

1.27

1.38

g/l

0.59

597

3799

Fentanyl

290

1464

2.05

27.36

2.4

1.7

1.14

1.46

g/l

2.02

255

1307

Triptan medication for migraine, min. 3 purchases

1902

11516

1.32

27.36

1.8

1.31

g/l

0.01

1778

10617

Unspecified chronic bronchitis

142

532

2.84

27.26

1.7

1.8

1.13

1.51

g/l

1.42

130

476

L01XE Protein kinase inhibitors

227

1060

2.29

27.14

3.3

1.8

1.95

1.48

g/l

0.77

200

972

Dermatophytosis

436

2522

1.80

27.13

2.0

1.9

1.34

1.36

g/l

0.03

393

2291

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1184

6592

1.42

27.10

1.9

1.5

1.38

1.19

g/l

1.41

1076

5971

Sacroiliitis, not elsewhere classified

198

871

2.41

27.10

1.6

1.9

1.28

1.43

g/l

0.99

193

812

Other specified/unspecified bacterial intestinal infections

243

1163

2.21

27.04

1.9

1.8

1.17

1.45

g/l

1.27

212

1059

Acute peritonitis

236

1117

2.23

27.01

1.9

1.07

1.43

g/l

2.48

216

1024

Myocardial infarction, without ST-elevation

1098

7177

1.44

26.97

1.8

1.9

1.25

1.39

g/l

0.97

985

6404

Open wound of lower leg

492

2944

1.73

26.95

1.8

1.23

1.34

g/l

0.69

443

2692

Cardiomyopathy (excluding other)

387

2163

1.85

26.88

1.6

1.9

1.16

1.42

g/l

1.45

361

1933

Allergic purpura

145

558

2.82

26.80

1.7

1.09

1.47

g/l

1.43

126

513

1109

7418

1.43

26.80

2.1

1.9

1.51

1.37

g/l

0.62

995

6606

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

988

6897

1.46

26.79

1.8

1.35

1.32

g/l

0.25

895

6391

Diseases of external ear

1068

7565

1.44

26.74

1.9

1.37

1.32

g/l

0.26

942

6894

Sleep disorders

730

4806

1.56

26.71

1.8

1.29

1.33

g/l

0.22

663

4435

Diseases of peritoneum

351

1913

1.91

26.70

1.8

1.9

1.10

1.42

g/l

3.37

324

1736

Deviated nasal septum

1042

7344

1.45

26.63

1.8

1.9

1.23

1.33

g/l

0.82

952

6703

Benign neoplasm: Small intestine

149

582

2.75

26.55

1.7

1.4

1.21

1.22

g/l

0.04

138

530

Pyothorax

170

709

2.57

26.46

2.3

1.7

1.39

1.40

g/l

0.02

155

651

Propionic acid derivatives

1065

3709

1.47

26.42

1.8

1.9

1.40

1.35

g/l

0.26

976

3404

Diabetic retinopathy, excluding more controls

873

3307

1.53

26.42

1.6

1.7

1.13

1.28

g/l

1.79

777

2962

Viral warts

361

1993

1.89

26.38

2.4

1.8

1.50

1.35

g/l

0.39

340

1836

Lichen simplex chronicus and prurigo

235

1121

2.21

26.37

2.0

1.8

1.24

1.36

g/l

0.38

210

1021

Other inflammation of eyelid

438

2560

1.77

26.25

2.2

1.8

1.37

1.36

g/l

0.04

401

2337

Infections with a predominantly sexual mode of transmission

1031

7284

1.44

26.04

1.9

1.8

1.35

1.31

g/l

0.26

933

6756

Certolizumab pegol

300

3.59

26.04

1.7

1.8

1.37

1.36

g/l

0.02

277

Generalized anxiety disorder

518

3168

1.68

25.97

1.7

1.8

1.37

1.31

g/l

0.31

472

2947

Other dialysis

148

589

2.76

25.80

2.0

1.8

1.09

1.48

g/l

1.44

137

544

Erosion of teeth, including avohilmo

657

4109

1.58

25.76

1.8

1.23

1.34

g/l

0.75

600

3784

Injuries to the shoulder and upper arm

2721

18426

1.25

25.76

1.9

1.27

1.31

g/l

0.38

2458

16826

Peripheral artery operations in Hilmo

372

2081

1.84

25.69

1.7

1.9

1.34

1.44

g/l

0.31

330

1840

N06DA Anticholinesterases

306

4541

0.54

25.55

1.5

1.9

1.58

1.43

g/l

0.23

246

3991

Use of anticholinesterases

306

4541

0.54

25.55

1.5

1.9

1.58

1.43

g/l

0.23

246

3991

Other/unspecified reactive arthropathies

259

1298

2.10

25.53

1.9

1.8

1.28

1.33

g/l

0.19

244

1195

Benign neoplasm of other and unspecified endocrine glands

388

2209

1.82

25.45

1.6

1.5

1.17

1.21

g/l

0.16

349

2013

Correction of physiology of bite - demanding therapy visit

270

1375

2.07

25.39

1.9

1.8

1.22

1.35

g/l

0.75

248

1269

Carpal tunnel syndrome

1934

13590

1.30

25.38

1.8

1.9

1.26

1.33

g/l

0.59

1766

12368

Mental and behavioural disorders due to opioids

169

717

2.52

25.33

1.4

1.8

1.63

1.24

g/l

3.08

161

659

Oter anti-inflammatory and antirheumatic agents, non-steroids

720

2588

1.57

25.30

1.8

1.9

1.27

1.43

g/l

0.80

650

2355

Valvular operations

417

2425

1.77

25.24

1.6

1.9

1.10

1.42

g/l

2.63

383

2164

Supplementary factors related to causes of morbidity and mortality classified elsewhere

988

6977

1.45

25.20

1.7

1.8

1.25

1.31

g/l

0.40

909

6412

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1017

4631

1.45

25.10

1.8

1.35

g/l

0.01

956

4321

Poisoning by medicine

745

4992

1.53

25.08

1.6

1.8

1.34

1.32

g/l

0.13

674

4631

Other enthesopathies

958

6736

1.45

24.96

1.9

1.46

1.37

g/l

0.45

867

6170

Anti-inflammatory and antirheumatic products, non-steroids

1056

3713

1.45

24.93

1.8

1.9

1.34

1.35

g/l

0.01

971

3408

Other obstetric conditions, not elsewhere classified

1041

4771

1.44

24.90

1.8

1.7

1.35

1.34

g/l

0.12

976

4450

Abnormalities of gait and mobility

381

2175

1.82

24.88

1.8

1.9

1.23

1.35

g/l

0.75

339

1967

Hypertensive Renal Disease

125

460

2.88

24.86

2.0

1.13

1.84

g/l

1.61

114

418

Cardiomyopathy, other and unspecified

262

1327

2.06

24.84

2.1

1.9

1.42

1.41

g/l

0.02

242

1198

Allergic urticaria

303

1618

1.96

24.67

2.0

1.8

1.32

1.35

g/l

0.14

278

1495

Seborrhoeic dermatitis

329

1807

1.90

24.47

2.0

1.9

1.46

1.34

g/l

0.35

291

1654

Pyoderma gangrenosum

131

5.34

24.42

2.2

1.6

1.07

1.46

g/l

0.82

120

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1348

6839

1.37

24.36

2.2

1.5

1.54

1.21

g/l

2.69

1196

6171

Personality disorders

913

6399

1.46

24.31

1.7

1.8

1.28

1.31

g/l

0.21

819

5938

KRA_PSY_EATING, excluding more controls

274

1412

2.00

24.28

1.6

1.8

1.16

1.42

g/l

3.89

253

1331

Lupus erythematosus

116

420

3.03

24.25

1.6

1.9

1.36

1.55

g/l

0.40

106

383

Acute gastritis

253

1277

2.07

24.21

1.8

1.9

1.34

1.39

g/l

0.13

231

1156

Other diseases of jaws

245

1224

2.09

24.20

2.5

1.7

1.11

1.41

g/l

2.00

219

1101

Other and unspecified disorders of skin and subcutaneous tissue

233

1145

2.14

24.19

2.2

1.8

1.26

1.45

g/l

0.78

193

1038

Nonorganic sleeping disorders

642

4204

1.57

24.18

1.8

1.9

1.31

1.32

g/l

0.05

588

3891

Type 1 diabetes, wide definition

745

5022

1.52

24.15

1.7

1.9

1.23

1.35

g/l

1.31

679

4621

Cerebral palsy and other paralytic syndromes

389

2253

1.79

24.12

2.0

1.9

1.42

1.37

g/l

0.11

359

2060

Atopic dermatitis, strict definition

1030

7236

1.42

24.07

1.8

1.20

1.29

g/l

1.20

969

6729

Postmenopausal osteoporosis with pathological fracture

192

879

2.31

23.93

1.9

1.8

1.36

1.43

g/l

0.20

170

758

Amenorrhoea

256

1303

2.05

23.92

2.1

1.8

1.39

1.41

g/l

0.08

236

1211

Cystic fibrosis with pulmonary manifestations

22.10

23.83

3.5

2.6

1.22

1.35

g/l

0.15

Endometriosis

1152

4946

1.41

23.81

1.7

1.8

1.37

1.35

g/l

0.14

1038

4492

Disorders of continuity of bone

333

1857

1.87

23.61

2.3

1.8

1.32

1.36

g/l

0.11

298

1711

Injuries to the wrist and hand

3362

20250

1.22

23.57

1.8

1.9

1.27

1.31

g/l

0.64

3063

18552

Hypopituitarism

282

1499

1.98

23.49

2.0

1.9

1.19

1.25

g/l

0.24

266

1401

Acute lymphadenitis

236

1180

2.10

23.41

2.3

1.8

1.14

1.32

g/l

0.68

215

1101

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1518

7854

1.34

23.41

2.1

1.5

1.50

1.22

g/l

2.68

1348

7113

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

681

4124

1.54

23.40

1.6

1.8

1.24

1.23

g/l

0.09

629

3863

Other benign neoplasms of skin

1014

7141

1.42

23.34

2.0

1.5

1.28

1.23

g/l

0.24

902

6488

Actinic keratosis

985

6680

1.43

23.31

2.1

1.9

1.54

1.39

g/l

0.59

879

5925

Degeneration of macula and posterior pole

1259

7692

1.37

23.28

2.0

1.9

1.44

1.38

g/l

0.27

1122

6855

Benign neoplasm: Transverse colon

329

1839

1.87

23.22

2.0

1.9

1.24

1.40

g/l

0.73

302

1656

Alcohol dependence

844

5881

1.47

23.20

1.5

1.9

1.34

1.32

g/l

0.14

752

5385

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1788

13732

1.30

23.12

1.9

1.8

1.33

1.30

g/l

0.18

1629

12588

Skin changes due to chronic exposure to nonionizing radiation

1015

6908

1.42

23.03

2.1

1.9

1.52

1.38

g/l

0.55

908

6138

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

543

3464

1.61

22.98

1.8

1.32

1.35

g/l

0.14

503

3191

Familial hypercholesterolemia

444

2695

1.69

22.96

1.8

1.24

1.48

g/l

0.92

403

2410

Fenamates

505

2100

1.66

22.87

1.8

1.9

1.24

1.44

g/l

1.07

464

1920

Other symptoms and signs involving the urinary system

337

1903

1.84

22.87

1.9

1.05

1.36

g/l

2.86

322

1720

TMD related operations

569

3681

1.59

22.75

1.8

1.9

1.27

1.31

g/l

0.26

527

3407

Ankylosing spondylitis, strict definition

191

895

2.27

22.68

1.5

1.9

1.20

1.31

g/l

0.63

183

839

Heartburn

318

1767

1.86

22.64

1.8

1.9

1.28

1.42

g/l

0.33

286

1607

Unspecific neurodegenerative disorder

478

5235

0.62

22.63

1.7

1.9

1.67

1.42

g/l

0.58

389

4629

Fracture of shoulder and upper arm

1097

8029

1.39

22.54

1.9

1.8

1.29

1.33

g/l

0.23

986

7300

Emotional disorders starting during childhood or adolecense, excluding more controls

175

771

2.33

22.54

1.9

1.8

1.28

1.21

g/l

0.45

159

723

Acute bronchiolitis

265

1250

2.00

22.53

2.1

1.8

1.16

g/l

0.03

253

1167

Filling of root of tooth

142

592

2.60

22.37

2.6

1.7

1.21

1.37

g/l

0.41

130

549

Faecal incontinence

268

1418

1.96

22.34

2.0

1.7

1.36

1.48

g/l

0.26

231

1277

Alzheimer disease, including avohilmo

356

4361

0.58

22.26

1.8

1.9

1.67

1.43

g/l

0.40

280

3840

Other and unspecified myopathies

278

1495

1.94

22.18

1.8

1.9

1.14

1.40

g/l

1.62

250

1357

Gingival hyperplasia

138

569

2.61

22.13

2.5

1.6

1.38

1.32

g/l

0.09

125

524

Conductive and sensorineural hearing loss

2483

13951

1.25

22.07

2.0

1.9

1.32

g/l

0.01

2236

12694

Other disorders of gingiva or/and edentulous alveolar ridge

182

844

2.27

22.02

2.3

1.7

1.40

g/l

0.00

167

765

Other disorders of optic [2nd] nerve and visual pathways

233

1187

2.07

22.00

2.3

1.8

1.07

1.41

g/l

2.84

212

1087

Colonic or urogenital fistula

860

6080

1.45

21.93

1.8

1.9

1.14

1.35

g/l

2.86

777

5567

Other and unspecified local infections of skin and subcutaneous tissue

323

1826

1.84

21.92

2.2

1.8

1.28

1.35

g/l

0.18

299

1671

Spondylolisthesis/Spondylolysis

560

3636

1.58

21.91

1.9

1.40

1.39

g/l

0.04

505

3303

Injuries to the hip and thigh

1354

9387

1.34

21.87

1.8

1.9

1.35

g/l

0.00

1214

8482

Other and unspecified psoriasis

237

1217

2.05

21.84

1.6

1.8

1.25

1.42

g/l

0.86

223

1118

Vitamin D deficiency

328

3.21

21.80

2.2

1.6

1.15

1.23

g/l

0.32

295

Radiculopathy

494

3120

1.62

21.77

1.9

1.39

g/l

0.02

454

2821

Myocardial infarction

1463

8013

1.33

21.74

1.8

2.0

1.17

1.41

g/l

3.53

1329

7214

DVT of lower extremities

556

3610

1.58

21.73

2.3

1.8

1.32

1.37

g/l

0.17

496

3257

Acute laryngitis and tracheitis

406

2404

1.71

21.72

2.0

1.7

1.22

1.29

g/l

0.48

376

2242

Other local infections of skin and subcutaneous tissue

341

1966

1.80

21.61

2.1

1.9

1.26

1.35

g/l

0.23

314

1800

Other bursopathies

412

2496

1.70

21.60

2.2

2.0

1.19

1.42

g/l

0.87

372

2272

Other follicular disorders

261

1390

1.96

21.55

2.0

1.8

1.27

1.40

g/l

0.46

241

1297

Disorders of adult personality and behaviour

944

6801

1.42

21.53

1.7

1.8

1.28

1.31

g/l

0.18

847

6318

Opening and dilatation of root channel of tooth

241

1253

2.02

21.44

2.2

1.8

1.30

1.31

g/l

0.04

220

1157

Migraine, single triptan purchase ok & required. ICD-code if available is included

2666

14798

1.23

21.39

1.8

1.27

1.30

g/l

0.27

2485

13574

Triptan medication for migraine, single purchase ok

2666

14798

1.23

21.39

1.8

1.27

1.30

g/l

0.27

2485

13574

Alcohol abuse, main dg, excluding more controls

472

2964

1.64

21.37

1.6

1.9

1.31

g/l

0.02

435

2741

Bullous disorders

200

975

2.16

21.31

1.8

1.28

1.45

g/l

0.56

189

886

Decubitus ulcer and pressure area

182

854

2.23

21.30

1.7

1.8

1.15

1.46

g/l

1.43

161

770

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

145

622

2.49

21.29

2.4

1.7

1.35

1.51

g/l

0.43

133

570

Diseases of tongue

215

1075

2.09

21.28

2.1

1.8

1.38

1.48

g/l

0.19

194

968

Acute posthaemorrhagic anaemia

125

500

2.65

21.20

2.6

1.8

1.62

1.57

g/l

0.05

111

455

Disorders of iron metabolism

271

3.47

21.16

1.4

1.6

0.99

1.41

g/l

2.02

250

Disorders of porphyrin and bilirubin metabolism

211

3.85

21.06

1.8

1.6

1.13

1.54

g/l

0.64

190

Angina pectoris

1769

9375

1.29

21.02

1.7

2.0

1.24

1.39

g/l

1.61

1626

8436

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1295

6709

1.35

20.93

2.3

1.5

1.52

1.21

g/l

2.40

1145

6052

Nasal polyp

596

3964

1.54

20.89

1.8

1.9

1.24

1.39

g/l

1.09

547

3603

Arthropathy in ulcerative colitis

232

3.66

20.85

1.7

1.33

1.45

g/l

0.24

214

Disorders of vestibular function (Vertigo)

1380

10508

1.32

20.79

1.9

1.26

1.36

g/l

1.13

1246

9508

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

572

3779

1.55

20.78

1.7

1.8

1.40

1.30

g/l

0.65

515

3511

Intestinal adhesions without obstruction

258

1384

1.94

20.70

1.8

1.14

1.39

g/l

1.24

235

1242

Vascular diseases of the intestine

132

548

2.55

20.69

1.7

1.8

1.31

1.53

g/l

0.46

121

493

Otitis media, unspecified

401

2241

1.70

20.67

2.2

1.8

1.20

1.29

g/l

0.44

378

2098

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1267

6581

1.35

20.50

2.2

1.5

1.49

1.21

g/l

1.99

1123

5933

Personal history of other diseases and conditions

386

2325

1.71

20.42

1.8

1.7

1.18

1.34

g/l

1.71

348

2169

Superficial injury of lower leg

776

5456

1.45

20.41

1.7

1.8

1.26

1.33

g/l

0.36

706

4990

Maternal care for other conditions predominantly related to pregnancy

676

4571

1.49

20.37

1.7

1.8

1.45

1.32

g/l

0.90

630

4248

Umbilical hernia

823

5855

1.43

20.28

1.7

1.9

1.34

1.33

g/l

0.06

753

5371

Sub-endpoint used in defining T1D endpoints

942

6738

1.40

20.19

1.7

1.9

1.23

1.31

g/l

0.92

860

6157

Speech and linguistic disorders, excluding more controls

285

1496

1.86

20.04

2.0

1.8

1.08

1.18

g/l

1.25

260

1399

Benign neoplasm: Duodenum

101

376

2.91

20.02

1.7

1.3

1.27

1.14

g/l

0.55

343

Carcinoma in situ of skin of other and unspecified parts of face

194

953

2.11

20.02

2.3

1.4

0.98

1.14

g/l

0.73

172

836

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

283

3.25

20.01

3.4

1.3

0.98

1.11

g/l

0.29

264

Fracture of foot, except ankle

774

5462

1.45

20.00

1.9

1.8

1.33

1.32

g/l

0.05

701

5040

TMD related pain

144

634

2.43

19.97

1.8

1.17

1.32

g/l

1.02

128

583

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

299

1700

1.83

19.95

1.8

1.48

1.36

g/l

0.32

273

1571

Other symptoms and signs involving cognitive functions and awareness

1259

8979

1.33

19.94

1.8

1.9

1.31

1.37

g/l

0.43

1123

8119

Allergic conjunctivitis

1855

14597

1.27

19.89

1.9

1.8

1.33

1.30

g/l

0.20

1693

13399

Isolated proteinuria with specified morphological lesion

225

3.69

19.88

2.0

1.5

1.63

1.52

g/l

0.08

207

Trochanteric bursitis

410

2536

1.66

19.84

1.8

1.9

1.38

1.43

g/l

0.17

371

2305

Bipolar affective disorders

608

4104

1.52

19.83

1.6

1.9

1.25

1.34

g/l

0.48

553

3809

Psoriasis (vulgaris), strict definition

137

593

2.48

19.82

1.4

1.8

1.28

1.34

g/l

0.17

127

553

Amputation of toe

224

1167

2.01

19.77

1.7

1.9

1.23

1.45

g/l

0.76

199

1057

Bronchitis, not specified as acute or chronic

281

1570

1.85

19.76

1.8

1.9

1.25

1.39

g/l

0.66

256

1437

Benign neoplasm of mouth and pharynx

319

1850

1.78

19.73

2.3

1.5

1.66

1.19

g/l

1.13

287

1677

Disorders of myoneural junction and muscle in diseases classified elsewhere

140

4.57

19.71

2.3

1.7

1.22

1.41

g/l

0.28

129

Benign neoplasm: Rectum, anus and anal canal

583

3912

1.53

19.67

2.0

1.8

1.56

1.36

g/l

0.72

534

3525

Stroke, excluding SAH

1728

10153

1.28

19.60

1.7

2.0

1.13

1.37

g/l

5.77

1538

9173

Other disorders of bladder

355

2125

1.72

19.57

2.3

1.9

1.15

1.42

g/l

1.74

306

1913

Ventral hernia

704

4902

1.47

19.56

1.7

1.9

1.36

g/l

0.02

642

4430

Diseases of inner ear

1608

12409

1.29

19.48

1.9

1.24

1.35

g/l

1.66

1449

11253

Carcinoma in situ of skin

212

1088

2.03

19.44

2.2

1.4

0.95

1.18

g/l

2.61

190

970

Seborrhoeic keratosis

621

4228

1.50

19.43

2.6

1.9

1.36

g/l

0.00

558

3807

Chronic iridocyclitis

188

929

2.13

19.41

2.1

1.8

1.34

1.46

g/l

0.36

178

854

Benign neoplasm: Stomach

317

1851

1.78

19.32

1.8

1.9

1.51

1.43

g/l

0.16

289

1675

Specific personality disorders

769

5458

1.44

19.24

1.6

1.8

1.32

g/l

0.02

691

5069

Epilepsy

939

6863

1.39

19.23

1.8

1.9

1.29

1.31

g/l

0.12

853

6275

Scleritis and episcleritis

217

1131

2.01

19.20

1.8

1.07

1.44

g/l

3.16

198

1040

Other hearing loss

734

5072

1.45

19.19

2.2

1.8

1.45

1.39

g/l

0.17

648

4528

Disorders of vitreous body and globe

1459

11107

1.30

19.17

1.9

1.32

1.35

g/l

0.17

1298

10051

Tubulo-interstitial nephritis, not specified as acute or chronic

217

1128

2.00

19.16

2.2

1.7

1.28

1.47

g/l

0.74

204

1013

Stroke, including SAH

1843

10897

1.27

19.15

1.7

2.0

1.14

1.36

g/l

5.99

1641

9839

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

248

1350

1.91

19.13

1.7

1.8

1.38

1.37

g/l

0.03

229

1267

Combinations of oral blood glucose lowering drugs

811

5816

1.42

19.10

1.4

2.0

1.01

1.38

g/l

12.95

732

5273

Vitamin B12 deficiency anaemia

308

1785

1.78

19.06

1.9

1.8

1.42

1.45

g/l

0.05

272

1598

Benign neoplasm: Ascending colon

395

2451

1.67

19.03

2.0

1.9

1.45

1.40

g/l

0.12

366

2202

Benign neoplasm: Rectum

521

3442

1.55

19.00

2.0

1.8

1.43

1.34

g/l

0.33

477

3104

Artrosis, including avohilmo

2875

13140

1.21

18.96

1.7

1.9

1.37

1.32

g/l

0.43

2616

12018

Insomnia

524

3468

1.55

18.95

1.7

1.9

1.20

1.36

g/l

1.78

484

3206

Other diseases of gallbladder

153

704

2.29

18.93

1.7

1.8

1.62

1.57

g/l

0.07

144

637

Hydronephrosis

320

1879

1.75

18.91

1.7

1.9

1.16

1.43

g/l

1.81

300

1692

Other female pelvic inflammatory diseases

519

3433

1.55

18.82

1.9

1.40

1.37

g/l

0.10

469

3144

Sensorineural hearing loss

2298

13178

1.23

18.74

2.0

1.9

1.33

g/l

0.02

2069

11975

Peripheral arterial reconstruction

441

2812

1.61

18.73

1.6

1.8

1.23

1.41

g/l

0.98

396

2481

Type of accident

879

6411

1.40

18.71

1.8

1.26

1.31

g/l

0.32

805

5884

Major coronary heart disease event

2089

11306

1.25

18.63

1.8

2.0

1.20

1.37

g/l

2.86

1899

10200

Mental and behavioural disorders due to tobacco

288

1655

1.81

18.62

1.7

1.9

1.25

1.36

g/l

0.36

263

1517

Abnormal findings on diagnostic imaging of central nervous system

164

783

2.21

18.56

2.5

1.9

1.18

1.37

g/l

0.86

157

727

Amputation of ankle bones

334

2.95

18.56

1.7

1.6

1.26

1.54

g/l

0.40

305

Enthesopathies of lower limb, excluding foot

670

4673

1.46

18.46

1.8

1.9

1.19

1.37

g/l

2.10

599

4278

Mental and behavioural disorders due to sedatives or hypnotics

247

1361

1.89

18.41

1.5

1.8

1.46

1.31

g/l

0.72

228

1256

Alzheimer’s disease, wide definition

203

3176

0.53

18.35

1.7

1.8

1.73

1.49

g/l

0.29

156

2795

Dental caries 2 and operation codes

2535

16726

1.22

18.35

1.9

1.8

1.31

1.29

g/l

0.16

2311

15387

Other and unspecified haemorrhagic conditions

266

3.23

18.31

2.3

1.5

1.18

1.41

g/l

0.33

244

Major coronary heart disease event excluding revascularizations

1889

10490

1.26

18.30

1.8

2.0

1.21

1.39

g/l

2.56

1704

9464

Smoking dependency

288

1664

1.80

18.28

1.7

1.8

1.25

1.36

g/l

0.37

263

1528

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

299

1748

1.77

18.15

1.8

1.9

1.48

1.37

g/l

0.31

273

1622

Chronic myeloproliferative disease

221

3.51

18.15

1.8

1.7

1.64

1.38

g/l

0.29

195

Infectious mononucleosis

299

1746

1.77

18.14

1.8

1.7

1.51

1.24

g/l

1.25

274

1627

Alzheimer disease

297

3765

0.59

18.11

1.8

1.56

1.46

g/l

0.15

227

3321

Disorders of vitreous body

1415

10852

1.29

18.10

1.9

1.32

1.35

g/l

0.15

1255

9819

Benign neoplasm of middle ear and respiratory system

227

1225

1.92

17.92

1.6

1.4

1.39

1.14

g/l

1.59

209

1120

Dental caries 2

2580

16904

1.21

17.88

1.9

1.8

1.31

1.29

g/l

0.12

2351

15548

Benign neoplasm: Sigmoid colon

524

3511

1.53

17.88

1.9

1.35

1.37

g/l

0.03

485

3158

Chorioretinal inflammation

120

514

2.51

17.83

2.1

1.8

1.28

1.57

g/l

0.66

110

469

Other localized connective tissue disorders

325

2.95

17.82

2.2

1.8

1.53

1.40

g/l

0.18

295

Noninflammatory disorders of female genital tract

1405

5476

1.31

17.60

1.8

1.34

1.35

g/l

0.10

1290

4988

Endocrine disorders, other/unspecified

350

2.86

17.59

2.2

1.5

1.16

1.36

g/l

0.61

325

Procreative management

1101

7052

1.34

17.58

1.9

1.8

1.29

1.27

g/l

0.12

1018

6538

Other abnormal uterine and vaginal bleeding

705

3541

1.45

17.56

1.9

1.42

1.36

g/l

0.33

629

3191

Disorders of refraction and accommodation

849

6203

1.39

17.50

2.0

1.8

1.36

1.28

g/l

0.44

779

5737

Suicide or other Intentional self-harm

788

5712

1.41

17.47

1.7

1.8

1.36

1.32

g/l

0.25

709

5282

Tonsillectomy and adenotomy

1944

10988

1.25

17.47

1.7

1.8

1.24

1.26

g/l

0.34

1809

10201

Other or ill-defined heart diseases

177

887

2.08

17.44

1.4

1.9

1.31

1.44

g/l

0.26

159

810

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

235

3.26

17.35

1.6

1.3

1.32

1.13

g/l

0.27

216

Fluid overload

8.29

17.32

3.1

1.7

3.10

1.06

g/l

0.70

Covid-19 suspected case

670

4737

1.44

17.22

2.1

1.8

1.41

1.31

g/l

0.37

628

4379

Drug-induced systemic lupus erythematosus

136

4.38

17.19

1.7

1.18

1.41

g/l

0.36

126

Other diseases of arteries and capillaries

276

1603

1.78

17.11

1.8

1.9

1.22

1.43

g/l

0.96

255

1448

Otitis externa

678

4811

1.44

17.10

1.9

1.31

1.33

g/l

0.05

609

4420

Asthma mixed form (mode), excluding more controls

156

751

2.15

17.01

1.7

1.30

1.37

g/l

0.17

150

673

Metatarsalgia

300

1789

1.73

16.89

1.9

1.57

1.42

g/l

0.37

269

1631

Essential (haemorrhagic) thrombocythaemia

124

550

2.38

16.86

2.0

1.4

1.36

1.21

g/l

0.34

109

499

Spontaneous rupture of synovium and tendon

258

1478

1.81

16.82

2.3

2.0

1.32

1.46

g/l

0.52

237

1327

Intrahepatic Cholestasis of Pregnancy (ICP)

248

1407

1.83

16.78

1.7

1.9

1.38

g/l

0.03

229

1322

Disturbance of activity and attention

354

2179

1.65

16.70

1.5

1.8

1.28

1.21

g/l

0.79

324

2038

Molar incisor enamel hypoplasia

151

719

2.22

16.65

2.7

1.9

1.03

1.08

g/l

0.30

146

684

Crystal arthropathies, rheuma endpoint

242

3.17

16.56

1.6

1.8

1.46

1.36

g/l

0.10

221

Persistent mood disorders

594

4140

1.46

16.52

1.7

1.8

1.37

1.36

g/l

0.01

526

3782

Cardiac murmurs and other cardiac sounds

295

1740

1.72

16.47

1.8

1.9

1.11

1.27

g/l

1.56

270

1596

Other enthesopathy of foot (+metatarsalgia)

318

1939

1.69

16.44

1.9

1.55

1.46

g/l

0.22

287

1771

Viral meningitis

146

702

2.20

16.35

1.9

1.7

1.25

1.27

g/l

0.08

135

653

Malnutrition

353

2.78

16.28

2.2

1.8

1.88

1.51

g/l

0.27

322

Pulmonary eosinophilia, not elsewhere classified

199

3.48

16.24

1.9

1.7

1.12

1.65

g/l

0.80

177

Superficial injury of head

670

4787

1.43

16.18

1.6

1.9

1.26

1.32

g/l

0.40

619

4370

IgA nephropathy (IgA glomerulonephritis)

107

457

2.53

16.13

1.7

1.6

1.14

1.37

g/l

1.02

100

422

Other crystal arthropathies

246

3.12

16.10

1.6

1.8

1.46

1.69

g/l

0.20

223

Cervicobrachial syndrome

659

4700

1.43

16.10

1.8

1.9

1.44

1.37

g/l

0.19

609

4296

Other disorders of veins

1141

8834

1.31

16.05

1.8

1.40

1.35

g/l

0.22

1023

8024

Social phobias

276

1633

1.74

16.00

1.9

1.8

1.30

g/l

0.02

257

1527

Iron deficiency

355

2.73

15.97

1.8

1.9

1.31

1.36

g/l

0.14

325

Other shoulder lesions

295

1779

1.71

15.94

1.9

1.44

1.41

g/l

0.10

271

1629

Vulvovaginal ulceration/inflammation in other diseases

195

1044

1.94

15.93

2.1

1.8

1.31

1.39

g/l

0.46

173

966

Lung cancer and mesothelioma

415

2302

1.57

15.91

1.8

1.7

1.62

1.47

g/l

0.34

377

2032

Other disorders of eyelid

1212

9147

1.30

15.88

1.9

1.29

1.38

g/l

0.58

1092

8210

Olecranon bursitis

203

1103

1.92

15.87

1.8

1.9

1.38

g/l

0.01

188

999

Chronic tubulo-interstitial nephritis

133

622

2.25

15.87

1.8

1.7

1.25

1.48

g/l

0.62

115

569

Autoimmune hyperthyroidism

168

855

2.03

15.81

1.8

1.28

1.45

g/l

0.79

155

771

Fitting and adjustment of other devices

897

6256

1.35

15.78

1.8

1.9

1.35

1.43

g/l

0.29

804

5583

Benign neoplasm: Small intestine

149

734

2.15

15.73

1.7

1.9

1.21

1.55

g/l

1.51

138

671

Use of pramipexole

618

4382

1.44

15.70

1.9

1.29

1.36

g/l

0.28

555

3959

Tuberculosis, IBD comorbidity

211

1161

1.88

15.70

1.8

1.34

1.46

g/l

0.21

190

1034

Nummular dermatitis

252

1465

1.78

15.66

2.0

1.9

1.38

1.35

g/l

0.08

229

1335

Asthma mixed form (mode)

156

776

2.08

15.63

1.7

1.30

1.38

g/l

0.18

150

699

Other disorders of glucose regulation and pancreatic internal secretion

268

1586

1.75

15.59

1.6

1.9

1.11

1.35

g/l

2.32

245

1461

Thyrotoxicosis, other and/or unspecified

590

4154

1.45

15.58

1.7

1.9

1.19

1.39

g/l

2.07

539

3807

Postprocedural disorders of digestive system, not elsewhere classified

118

532

2.35

15.53

1.9

1.7

1.09

1.41

g/l

1.28

109

493

Unspecified nephritic syndrome

100

422

2.56

15.49

2.0

1.6

1.26

1.51

g/l

0.45

386

Dipeptidyl peptidase 4 (DPP-4) inhibitors

333

2086

1.64

15.48

1.4

1.9

1.09

1.47

g/l

2.98

298

1863

Ischaemic Stroke, excluding all haemorrhages

1567

9533

1.26

15.45

1.7

2.0

1.10

1.38

g/l

8.46

1398

8589

Juvenile rheumatoid arthirtis

385

2.60

15.38

2.2

1.7

1.20

1.39

g/l

0.79

355

Other/unspecified synovitis and tenosynovitis

355

2260

1.61

15.37

1.7

1.9

1.31

1.42

g/l

0.28

317

2059

Polycythaemia vera

108

470

2.42

15.35

1.8

1.3

1.70

1.18

g/l

1.34

423

Abnormal involuntary movements

403

2643

1.57

15.34

1.9

1.29

1.37

g/l

0.24

368

2415

Infective dermatitis

345

2185

1.62

15.30

1.8

1.9

1.35

1.32

g/l

0.10

316

1986

Presbycusis

327

2029

1.64

15.29

2.3

1.8

1.71

1.38

g/l

0.62

279

1771

Benign paroxysmal vertigo

807

6003

1.37

15.27

2.0

1.9

1.29

1.39

g/l

0.78

735

5451

Other sleep disorders

337

2124

1.63

15.26

1.9

2.0

1.16

1.41

g/l

1.82

309

1933

Respiratory conditions due to other external agents

323

2.78

15.22

2.7

1.6

1.29

1.58

g/l

0.35

290

Monoarthritis, not elsewhere classified

141

686

2.15

15.17

1.5

1.9

1.43

1.45

g/l

0.04

132

622

Erythema multiforme

407

2.56

15.16

2.1

1.7

1.03

1.52

g/l

1.76

378

Melanocytic naevi

880

6640

1.35

15.12

2.1

1.8

1.41

1.32

g/l

0.45

817

6082

In situ neoplasms

1000

7678

1.32

15.11

2.1

1.8

1.18

1.38

g/l

3.14

897

6938

Unspecified urinary incontinence

267

1593

1.73

15.10

1.8

1.39

1.38

g/l

0.02

226

1431

694

4458

1.40

15.08

1.9

1.49

1.41

g/l

0.25

609

3917

Oesophagitis

172

901

1.99

15.05

1.5

1.8

1.07

1.41

g/l

1.69

156

814

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

545

3686

1.47

15.04

1.8

1.9

1.23

1.28

g/l

0.38

526

3420

Abscess of anal and rectal regions

271

1624

1.72

15.04

1.6

1.9

1.20

1.36

g/l

1.09

251

1508

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

248

1453

1.77

15.04

1.5

1.8

1.59

1.22

g/l

3.40

229

1347

Hidradenitis suppurativa

136

658

2.18

14.99

1.5

1.8

1.16

1.33

g/l

0.95

120

614

Other noninflammatory disorders of vulva and perineum

279

1686

1.70

14.96

1.8

1.36

1.39

g/l

0.08

254

1537

Arthropathy in Crohn disease

189

3.46

14.92

1.7

1.5

1.44

1.31

g/l

0.30

174

Meningitis

178

949

1.96

14.86

2.2

1.8

1.37

1.38

g/l

0.01

161

874

Hyperhidrosis

408

2.49

14.84

2.3

1.6

1.43

1.28

g/l

0.18

372

Chondropathies

495

3411

1.49

14.79

1.8

1.21

1.35

g/l

0.91

442

3161

Other erythematous conditions

129

616

2.22

14.76

1.7

1.24

1.46

g/l

0.70

118

571

Delirium, not induced by alcohol and other psychoactive substances

293

1796

1.67

14.75

1.8

1.41

1.40

g/l

0.02

257

1608

Mouth breathing

1254

9934

1.28

14.74

1.7

1.9

1.26

1.30

g/l

0.22

1143

9123

Osteopathy in diseases classified elsewhere

127

4.15

14.64

6.1

1.8

0.63

1.35

g/l

1.87

114

Corneal ulcer

554

3905

1.45

14.60

1.8

1.18

1.31

g/l

1.39

509

3587

Alzheimer’s disease (Late onset)

184

2830

0.55

14.57

1.7

1.8

1.74

1.51

g/l

0.25

140

2476

Benign neoplasm of other and unspecified endocrine glands

388

2558

1.56

14.48

1.6

1.9

1.17

1.39

g/l

1.48

349

2329

Other disorders of nervous system

213

1210

1.83

14.46

2.6

1.8

1.70

1.43

g/l

0.32

188

1100

Pleural plaque

254

1514

1.73

14.36

1.7

1.9

1.21

1.46

g/l

0.61

224

1341

Disorders of psychological development

403

2480

1.54

14.33

1.9

1.8

1.09

1.16

g/l

0.94

371

2308

Speech therapy

785

5874

1.36

14.33

1.9

1.32

1.34

g/l

0.05

739

5343

Extreme obesity with alveolar hypoventilation

143

718

2.10

14.30

2.0

1.8

1.23

1.38

g/l

0.40

133

658

Bacterial, viral and other infectious agents

290

1795

1.67

14.28

2.1

1.8

1.21

1.29

g/l

0.38

261

1672

Benign neoplasm: Duodenum

101

445

2.44

14.22

1.7

1.8

1.27

1.56

g/l

0.73

406

Benign neoplasm: Descending colon

180

975

1.92

14.21

1.9

1.4

1.53

1.17

g/l

0.81

164

890

Injuries to the neck

693

5099

1.38

14.14

2.0

1.8

1.36

1.34

g/l

0.08

635

4691

Benign neoplasm: Adrenal gland

205

1158

1.83

14.13

1.6

1.4

1.08

1.17

g/l

0.32

181

1056

Superficial injury of hip and thigh

396

2632

1.54

14.07

1.7

1.9

1.32

1.38

g/l

0.18

358

2371

Emotionally unstable personality disorder

397

2647

1.54

14.01

1.7

1.8

1.35

1.34

g/l

0.06

360

2468

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

260

1566

1.70

13.99

2.2

1.4

1.67

1.17

g/l

1.33

229

1380

Melanocytic naevi of trunk

329

2107

1.60

13.94

2.1

1.6

1.33

1.22

g/l

0.67

310

1942

Cluster headache, strict

130

636

2.15

13.91

1.6

1.8

1.12

1.35

g/l

1.52

117

590

Other specified/unspecified soft tissue disorders

155

806

2.00

13.87

2.0

1.7

1.06

1.57

g/l

3.48

148

727

Hyperkinetic disorders

370

2405

1.56

13.86

1.5

1.8

1.27

1.21

g/l

0.55

340

2249

Iridocyclitis in diseases classified elsewhere

333

2.67

13.86

1.9

1.7

1.19

1.65

g/l

1.20

307

Other predominantly sexually transmitted diseases, not elsewhere classified

544

3862

1.44

13.80

2.0

1.8

1.33

1.31

g/l

0.10

490

3587

Mixed hyperlipidaemia

136

679

2.10

13.76

1.4

1.8

1.07

1.46

g/l

2.04

121

617

Prurigo nodularis

413

2.46

13.74

1.9

1.8

0.96

1.32

g/l

1.93

371

Anosmia

213

3.00

13.72

1.5

1.6

1.05

1.42

g/l

1.60

197

Tuberculosis, wide

214

1233

1.79

13.71

1.8

1.9

1.33

1.48

g/l

0.27

193

1096

Unspecified privation

329

2119

1.60

13.67

2.0

1.9

1.19

1.37

g/l

1.56

304

1939

Pain associated with micturition

345

2245

1.58

13.67

2.2

1.9

1.53

1.37

g/l

0.31

315

2049

Other specific arthropathies, wide

328

2.63

13.61

2.0

1.8

1.11

1.41

g/l

1.20

301

Otitis externa, unspecified

338

2193

1.58

13.60

2.0

1.8

1.34

1.39

g/l

0.11

313

2020

Atypical facial pain

167

898

1.94

13.59

2.4

1.7

1.69

1.39

g/l

0.39

154

817

Use of memantine

239

3418

0.60

13.57

1.8

1.94

1.47

g/l

0.63

180

3001

Use of other anti-dementia drugs

239

3418

0.60

13.57

1.8

1.94

1.47

g/l

0.63

180

3001

Diabetic neuropathy

358

2346

1.57

13.55

1.7

1.21

1.20

g/l

0.03

324

2129

Cluster headache, wide

135

678

2.08

13.44

1.6

1.8

1.10

1.42

g/l

1.67

122

627

Paralytic ileus

119

570

2.18

13.42

1.8

1.7

1.29

1.54

g/l

0.59

111

522

Heart failure and hypertrophic cardiomyopathy

279

2.80

13.40

1.7

1.6

1.52

1.47

g/l

0.03

253

Other blood glucose lowering drugs, excl. Insulins

451

3114

1.48

13.32

1.6

1.9

1.20

1.45

g/l

1.45

420

2786

Haemangioma and lymphangioma, any site

256

1562

1.69

13.32

1.9

1.5

1.35

1.22

g/l

0.64

243

1433

Benign neoplasm of major salivary glands

256

1561

1.69

13.31

1.7

1.4

1.26

1.19

g/l

0.24

232

1411

Haemangioma, any site

242

1456

1.71

13.30

2.0

1.5

1.37

1.22

g/l

0.78

231

1339

Impetigo

165

892

1.94

13.27

2.4

1.7

1.53

1.37

g/l

0.25

158

831

Neuralgia and neuritis, unspecified

164

883

1.93

13.27

2.3

1.8

1.63

1.53

g/l

0.13

152

799

Benign neoplasm of eye and adnexa

263

1617

1.67

13.25

2.0

1.5

1.28

1.20

g/l

0.22

236

1467

Cervicocranial syndrome

322

2079

1.59

13.20

1.8

1.9

1.27

1.42

g/l

0.49

303

1891

Other keratitis

341

2233

1.57

13.16

1.8

1.21

1.39

g/l

1.62

316

2056

Presence of other devices

554

3970

1.42

13.16

1.6

1.8

1.41

1.45

g/l

0.09

515

3539

Scoliosis

261

1607

1.67

13.09

2.0

1.8

1.15

1.45

g/l

2.74

243

1479

Thyroiditis

232

1389

1.73

13.08

1.8

1.30

1.42

g/l

0.43

210

1270

Other extrapyramidal and movement disorders in other diseases

622

4562

1.39

13.02

1.8

1.9

1.39

1.36

g/l

0.11

559

4139

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

121

588

2.13

13.01

2.3

1.4

1.48

1.20

g/l

0.51

109

529

Acute alcohol intoxication, ICD10

593

4317

1.40

13.00

1.6

1.9

1.34

1.29

g/l

0.27

534

3982

Unspecified/other endometriosis

280

1756

1.64

13.00

1.8

1.23

1.40

g/l

2.02

258

1614

Other endocrine disorders

211

1189

1.78

12.96

2.4

1.8

1.11

1.18

g/l

0.41

198

1111

Scleritis

227

3.00

12.95

1.9

1.7

1.03

1.33

g/l

1.04

212

Insulin, fast-acting (human)

443

3067

1.47

12.92

1.6

1.9

1.20

1.37

g/l

2.03

400

2819

Agoraphobia

118

573

2.16

12.91

2.0

1.7

1.17

1.31

g/l

0.90

106

534

Vitreous haemorrhage

293

1865

1.62

12.86

1.7

1.9

1.06

1.40

g/l

3.29

250

1694

Leisure time condition

524

3748

1.43

12.79

1.8

1.9

1.25

1.34

g/l

0.49

473

3429

Nonspecific lymphadenitis

204

1187

1.78

12.78

2.1

1.8

1.16

1.34

g/l

0.64

188

1101

Alcohol-induced chronic pancreatitis

213

1256

1.76

12.76

1.5

1.9

1.26

1.39

g/l

0.59

198

1169

Chronic conjunctivitis

116

564

2.18

12.75

1.8

1.05

1.29

g/l

1.50

108

522

Other bacterial agents as the cause of diseases classified to other chapters

180

3.29

12.74

2.9

1.7

1.54

1.80

g/l

0.19

164

Other disorders of conjunctiva

397

2705

1.50

12.66

1.8

1.9

1.16

1.39

g/l

1.95

368

2434

Episcleritis

176

985

1.86

12.65

1.9

1.7

1.06

1.34

g/l

2.27

159

912

Use of donepezil

172

2894

0.56

12.62

1.8

1.43

1.47

g/l

0.06

137

2529

Other meningitis

306

2.66

12.60

2.2

1.7

1.69

1.35

g/l

0.23

283

Algoneurodystrophy

120

593

2.13

12.59

1.9

1.6

1.33

1.31

g/l

0.05

113

552

Benign neoplasm: Parotid gland

210

1235

1.75

12.58

1.7

1.4

1.34

1.17

g/l

0.56

188

1123

Panniculitis, unspecified

181

3.25

12.58

2.2

1.7

1.39

1.43

g/l

0.05

162

Visual impairment including blindness (binocular or monocular)

196

1132

1.79

12.55

1.8

1.18

1.51

g/l

1.33

166

1027

Pneumonitis due to solids and liquids

214

1265

1.74

12.55

1.5

1.9

1.22

1.40

g/l

0.73

184

1147

Inflammatory disease of uterus

424

2931

1.48

12.52

1.8

1.38

1.36

g/l

0.07

379

2702

Superficial injury of wrist and hand

605

4447

1.39

12.51

1.8

1.35

1.32

g/l

0.13

559

4113

Diseases of male genital organs

1662

6918

1.23

12.49

1.9

1.17

1.24

g/l

0.57

1528

6348

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1153

9218

1.26

12.49

1.8

1.39

1.28

g/l

0.92

1063

8537

Myocardial infarction, strict

1285

7569

1.25

12.40

1.7

2.0

1.22

1.41

g/l

1.81

1171

6797

Other disorders of the musculoskeletal system and connective tissue

422

2923

1.48

12.38

1.9

1.35

1.40

g/l

0.13

390

2666

Correction of physiology of bite - very demanding therapy visit

112

544

2.18

12.38

2.1

1.7

1.25

1.37

g/l

0.39

107

507

Striking against or struck by other objects

997

7857

1.29

12.37

1.8

1.9

1.35

1.27

g/l

0.46

891

7250

Degenerative diseases of the nervous system

414

4483

0.69

12.35

1.8

1.63

1.42

g/l

0.55

336

3969

Cluster headache, strict, including avohilmo

170

950

1.87

12.31

1.6

1.8

1.13

1.36

g/l

1.91

157

884

Pneumothorax

201

1176

1.76

12.30

2.0

1.8

1.16

1.40

g/l

1.34

186

1072

Cardiac arrest

156

721

1.91

12.29

1.5

2.1

1.32

1.78

g/l

1.40

140

649

Preparation and fitting of bite rail to mouth

430

2994

1.47

12.29

1.8

1.9

1.31

g/l

0.01

404

2774

Artificial joint operation, meniscal resection

2800

16128

1.16

12.23

1.9

1.28

1.32

g/l

0.40

2532

14676

Other and unspecified erythematous conditions

112

547

2.16

12.17

1.7

1.19

1.49

g/l

1.03

102

507

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

220

1326

1.72

12.12

1.8

1.37

1.34

g/l

0.07

204

1229

Fracture of lower leg, including ankle

1646

13656

1.21

12.11

1.8

1.9

1.24

1.31

g/l

1.00

1518

12446

Other disorders starting during childhood or adolecense, excluding more controls

168

904

1.86

12.07

1.9

1.8

1.18

1.15

g/l

0.12

160

850

Combined immunodeficiencies

191

3.11

12.04

4.2

1.6

1.29

1.77

g/l

0.58

174

Corns and callosities

204

1207

1.75

12.03

1.8

1.17

1.35

g/l

0.86

188

1094

Otalgia

245

1521

1.66

12.01

1.9

1.8

1.37

1.34

g/l

0.05

222

1400

Localized scleroderma [morphea]

242

2.82

11.96

1.8

1.6

1.42

1.44

g/l

0.03

222

Abscess of lung

272

2.72

11.94

2.8

1.6

1.28

1.67

g/l

0.66

252

Benign neoplasm of meninges

255

1598

1.64

11.94

1.9

1.4

1.52

1.24

g/l

0.52

225

1449

Acne

321

2118

1.55

11.94

1.6

1.7

1.23

1.28

g/l

0.40

293

1972

Congenital malformations of trachea and bronchus

177

3.24

11.88

1.7

1.9

0.95

1.33

g/l

1.29

167

Barrett oesophagus

147

794

1.93

11.87

1.5

1.9

1.24

1.35

g/l

0.28

133

722

Alcohol abuse, main dg

472

3362

1.43

11.87

1.6

1.8

1.31

g/l

0.01

435

3109

Carcinoma in situ of skin of scalp and neck

271

2.66

11.84

2.5

1.3

0.94

1.11

g/l

0.47

244

Cluster headache, wide,, including avohilmo

175

999

1.82

11.80

1.6

1.8

1.12

1.39

g/l

2.03

162

929

Acquired pure red cell aplasia [erythroblastopenia]

5.02

11.78

1.9

1.7

1.03

1.18

g/l

0.30

Erythema nodosum

108

527

2.16

11.76

2.2

1.7

1.04

1.43

g/l

1.77

483

Childhood allergy (age < 16)

484

2841

1.43

11.75

1.7

1.8

1.22

1.21

g/l

0.12

446

2645

Other epidermal thickening

143

769

1.94

11.73

1.9

1.7

1.20

1.42

g/l

0.56

134

699

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1739

11893

1.20

11.71

1.8

1.27

1.35

g/l

1.32

1605

10874

Emotional disorders and disorders of social functioning with onset specific to childhood

187

1074

1.78

11.71

1.8

1.28

1.20

g/l

0.46

170

1000

Tongue abnormality

190

1113

1.77

11.70

2.0

1.8

1.27

1.47

g/l

0.67

172

1009

Traumatic subdural haemorrhage

310

2004

1.55

11.64

1.8

1.9

1.68

1.44

g/l

0.52

264

1786

Leiomyoma of uterus

1379

6340

1.24

11.58

1.8

1.6

1.25

1.31

g/l

0.62

1251

5800

Charcot foot

294

2.60

11.55

1.9

1.8

1.73

1.83

g/l

0.07

273

Congenital malformations of the respiratory system

364

2.45

11.54

1.7

2.0

0.91

1.36

g/l

1.62

344

Thyrotoxicosis

715

5454

1.33

11.53

1.8

1.9

1.20

1.35

g/l

1.61

655

4970

Eating disorder

274

1760

1.59

11.51

1.6

1.7

1.16

1.38

g/l

3.37

253

1645

Other noninfective disorders of lymphatic vessels and lymph nodes

119

606

2.06

11.50

2.2

1.8

1.33

1.38

g/l

0.09

108

559

Diabetic retinopathy

1021

5116

1.28

11.45

1.6

1.7

1.12

1.24

g/l

1.51

907

4623

Carcinoma in situ of skin of other and unspecified parts of face

194

1149

1.74

11.38

2.3

1.8

0.98

1.52

g/l

3.41

172

1004

Ulcer of oesophagus

189

1113

1.75

11.32

1.9

2.0

1.46

1.41

g/l

0.08

168

1002

Other eating disorders

172

989

1.80

11.27

1.7

1.17

1.36

g/l

1.92

158

922

Emotional disorders starting during childhood or adolescence

178

1026

1.78

11.27

1.8

1.29

1.21

g/l

0.48

162

957

Retinal detachments and breaks

925

7314

1.28

11.25

2.0

1.9

1.44

1.36

g/l

0.30

847

6590

Disorders of orbit

147

809

1.89

11.23

1.8

1.7

1.17

1.42

g/l

1.37

134

741

474

3220

1.42

11.21

1.7

1.9

1.22

1.44

g/l

1.27

415

2832

Left ventricular outflow tract obstruction (LVOTO), broad definition

323

2171

1.53

11.18

1.7

1.9

1.14

1.24

g/l

0.67

298

2021

Endometriosis of pelvic peritoneum

473

3358

1.41

11.17

1.7

1.8

1.42

1.35

g/l

0.43

415

3071

Open wound of wrist and hand

1295

10528

1.23

11.13

1.8

1.9

1.29

g/l

0.04

1182

9671

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

444

2.23

11.12

1.8

1.3

1.28

1.18

g/l

0.14

405

Acquired absence of limb

129

3.49

11.12

1.8

1.7

0.99

1.59

g/l

0.64

117

Dementia

613

5625

0.74

11.11

1.7

1.9

1.60

1.41

g/l

0.54

520

4994

Gonarthrosis,primary

2685

14676

1.16

11.08

1.9

1.29

1.34

g/l

0.48

2399

13362

Other primary thrombocytopenia

4.84

11.04

2.1

1.6

0.91

1.28

g/l

1.12

Other disorders of patella

492

3570

1.40

11.04

1.7

1.9

1.26

1.35

g/l

0.46

440

3274

Artificial opening status

160

908

1.83

11.03

2.3

1.9

1.14

1.48

g/l

1.73

148

831

Disease of hard tissues of teeth, NOS

195

2.98

11.02

2.1

1.5

1.04

1.37

g/l

1.08

182

Strabismus

802

6240

1.30

11.02

1.9

1.8

1.25

1.31

g/l

0.53

750

5738

Sequelae of cerebrovascular disease

875

6034

1.29

11.00

1.6

1.9

1.19

1.43

g/l

3.00

780

5384

Nail disorders

254

1627

1.61

10.96

1.8

1.9

1.34

1.33

g/l

0.04

229

1492

Superficial injury of thorax

422

2991

1.44

10.94

1.7

1.9

1.37

1.36

g/l

0.04

388

2721

Sequelae of other external causes

165

947

1.81

10.92

2.3

1.8

1.43

g/l

0.00

151

871

Benign neoplasm of urinary organs

127

672

1.96

10.90

1.6

1.4

1.51

1.21

g/l

0.56

116

613

Aortic aneurysm

560

4082

1.37

10.88

2.1

1.9

1.14

1.44

g/l

2.44

506

3634

Superficial injury of abdomen, lower back and pelvis

434

3094

1.43

10.88

1.8

1.26

1.35

g/l

0.50

394

2839

Fracture of femur

631

4344

1.34

10.85

1.8

1.38

1.37

g/l

0.05

552

3866

Lichen planus

359

2478

1.48

10.81

1.6

1.9

1.29

1.37

g/l

0.38

325

2249

Appendectomy

2030

16754

1.18

10.74

1.8

1.26

1.30

g/l

0.49

1866

15357

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

121

634

1.99

10.74

2.3

1.4

0.94

1.18

g/l

1.46

110

583

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

231

1456

1.64

10.70

1.9

1.8

1.44

1.41

g/l

0.08

212

1321

Speech and linguistic disorders

303

1944

1.54

10.70

2.1

1.8

1.07

1.16

g/l

1.01

277

1813

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

138

757

1.90

10.69

1.7

1.8

1.21

1.26

g/l

0.24

128

709

Anogenital herpesviral [herpes simplex] infection

196

1187

1.70

10.65

2.0

1.8

1.33

1.34

g/l

0.03

179

1114

Carcinoma in situ of skin

212

1310

1.67

10.64

2.2

1.8

0.95

1.54

g/l

6.74

190

1163

Hallux valgus (acquired)

904

5166

1.28

10.63

1.8

1.37

g/l

0.03

807

4668

Brachial plexus disorders

288

1909

1.55

10.63

1.8

1.37

1.29

g/l

0.17

273

1761

Unspecified misadventure during surgical and medical care

169

987

1.78

10.59

2.0

1.8

1.41

1.48

g/l

0.16

158

905

Retinal vascular disorders

299

1996

1.53

10.59

2.2

1.9

1.58

1.42

g/l

0.38

277

1779

Chondrocostal junction syndrome [Tietze]

125

667

1.96

10.58

1.7

1.8

1.21

1.41

g/l

1.03

109

610

Lichen ruber planus, wide definition including periferal and oral lichen planus

583

4384

1.35

10.49

1.6

1.9

1.37

1.35

g/l

0.08

538

3980

Retinal vascular occlusion

295

1969

1.53

10.47

2.2

1.9

1.54

1.42

g/l

0.27

273

1755

Injuries to the elbow and forearm

2125

16540

1.17

10.46

1.8

1.9

1.30

g/l

0.02

1928

15121

Familial hypercholesterolemia, with ischemic heart disease

244

1564

1.60

10.45

1.6

1.9

1.44

1.53

g/l

0.14

221

1368

Any dementia

519

4931

0.73

10.44

1.8

1.9

1.51

1.41

g/l

0.23

434

4362

Benign neoplasm of mouth and pharynx

319

2168

1.51

10.44

2.3

1.8

1.66

1.38

g/l

0.53

287

1970

Abnormal blood-pressure reading, without diagnosis

133

725

1.90

10.43

2.2

1.8

1.08

1.40

g/l

2.49

118

654

Adhesive capsulitis of shoulder

467

3395

1.40

10.43

1.6

1.9

1.29

1.41

g/l

0.50

429

3087

Acidosis

327

2.42

10.42

1.6

1.7

1.24

1.51

g/l

0.48

302

Collapsed vertebra, not elsewhere classified

109

3.66

10.42

3.2

2.1

0.77

2.04

g/l

1.29

Calculus of kidney and ureter

823

6483

1.29

10.40

1.9

1.22

1.36

g/l

0.96

754

5894

Lesion of lateral popliteal nerve

156

895

1.81

10.39

2.1

1.7

1.18

1.28

g/l

0.30

139

823

TMD muscular pain linked with fibromyalgia

168

3.10

10.37

1.7

1.8

1.20

1.40

g/l

0.42

155

Dementia, including avohilmo

677

6061

0.76

10.34

1.7

1.9

1.60

1.41

g/l

0.63

576

5376

Alcohol withdrawal state with delirium

213

1329

1.65

10.33

1.3

1.9

1.56

1.39

g/l

0.49

189

1229

Assault

408

2908

1.43

10.30

1.5

1.8

1.45

1.28

g/l

1.05

372

2711

Sulfonylureas

891

5637

1.28

10.30

1.5

2.0

1.16

1.47

g/l

3.29

805

5023

Other and unspecified iridocyclitis

139

774

1.87

10.27

1.9

1.7

1.23

1.44

g/l

0.60

133

713

Trigeminal neuralgia

174

1032

1.74

10.25

1.9

1.7

1.13

1.36

g/l

1.01

162

934

Carcinoma in situ of skin of trunk

366

2.29

10.25

2.3

1.3

1.32

1.14

g/l

0.32

332

Fall on same level involving ice and snow

1668

14134

1.19

10.24

1.8

1.9

1.31

1.32

g/l

0.06

1520

12878

Burkitt lymphoma, excluding all cancers (controls excluding all cancers)

16.19

10.24

3.1

1.2

1.11

1.21

g/l

0.11

Superficial injury of ankle and foot

365

2554

1.46

10.24

1.9

1.8

1.27

1.30

g/l

0.14

326

2375

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgM [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS